Expandable mouth catheter

Information

  • Patent Grant
  • 11529495
  • Patent Number
    11,529,495
  • Date Filed
    Thursday, September 10, 2020
    3 years ago
  • Date Issued
    Tuesday, December 20, 2022
    a year ago
Abstract
A catheter system that is actuatable to a deployed state and includes a catheter body and a dilator positioned at least partially within the lumen of the catheter. A distal end of the dilator can be releasably connected to a distal tip of the catheter body. The dilator can be retractable to expand and invert the distal tip and form a funnel shape in the deployed state.
Description
FIELD

The present disclosure generally relates to devices and methods for removing acute blockages from blood vessels during intravascular medical treatments. More specifically, the present disclosure relates to an expandable catheter used in aspiration of clots.


BACKGROUND

Clot retrieval catheters and devices are used in mechanical thrombectomy for endovascular intervention, often in cases where patients are suffering from conditions such as acute ischemic stroke (AIS), myocardial infarction (MI), and pulmonary embolism (PE). Accessing remote areas such as the neurovascular bed is challenging with conventional technology, as the target vessels are small in diameter, distant relative to the site of insertion, and are highly tortuous.


The clot itself can complicate procedures by taking on a number of complex morphologies and consistencies, ranging from simple tube-shaped structures which assume the shape of the vessel to long, strand-like arrangements that can span multiple vessels at one time. The age of a clot can also affect its compliance, with older clots tending to be less compressible than fresh clots. Fibrin rich clots also present a challenge in having a sticky nature that can cause a clot to roll along the outer surface of a mechanical thrombectomy device rather than being gripped effectively. Combinations of soft and firm clot regions can also separate during aspiration, with fragmentation leading to distal embolization which can occur in vessels that cannot be reached with currently available devices. Additionally, breaking the bonds adhering the clot to the vessel wall without damaging fragile vessels is a significant challenge.


Conventional clot retrieval catheters, especially those for operating in the neurovascular, can suffer from a number of drawbacks. First, the diameters of the catheters themselves must be small enough to avoid causing significant discomfort to the patient. The catheter must also be sufficiently flexible to navigate the vasculature and endure high strains, while also having the axial stiffness to offer smooth advancement along the route. Once at the target site, typical objects to be retrieved from the body can be substantially larger in size than the catheter tip, making it more difficult to retrieve objects into the tip. For example, fibrin-rich clots can often be difficult to extract as they can become lodged in the tip of traditional fixed-mouth catheters. This lodging can cause softer portions of the clot to shear away from the firmer regions, leading to distal embolization.


Small diameters and fixed tip sizes can also be less efficient at directing the aspiration necessary to remove blood and thrombus material during the procedure. The aspiration suction must be strong enough such that any fragmentation occurring through the use of a mechanical thrombectomy device or other methods can, at the very least, be held stationary so that fragments cannot migrate and occlude distal vessels. When aspirating with a traditional fixed-mouth catheter, however, a significant portion of the aspiration flow ends up coming from vessel fluid proximal to the tip of the catheter where there is no clot. This significantly reduces aspiration efficiency, lowering the success rate of clot removal.


The disclosed design is aimed at providing an improved aspirating retrieval catheter which addresses the above-stated deficiencies.


SUMMARY

It is an object of the present design to provide systems, devices, and methods to meet the above-stated needs. The design features an expandable catheter with an expandable clot-facing mouth for flow restriction, aspiration efficiency, and easy retrieval of the clot while also having a collapsed state that is low-profile and sufficiently flexible for delivery in a standard sheath or outer catheter. The catheter can also have a tailored, variable-stiffness body section incorporating deliverability enhancements over existing designs and capable of navigating tortuous areas of the vasculature to reach an occlusive clot.


In some examples, a catheter system is disclosed that is actuatable to a deployed state. The system can include a catheter body with a lumen. A dilator can be positioned at least partially within the lumen, a distal end of the dilator being connected to a distal tip of the catheter body. The dilator can be retractable to expand and invert the distal tip to form a funnel shape in the deployed state.


In some examples, the distal tip can include a proximal segment and a distal segment extended from the proximal segment and being substantially flexible. A proximal end of the distal segment can be extended from the proximal segment and can include a pull ring adjacent and/or connected to a distal end of the distal segment.


In some examples, a midpoint of the distal segment in a collapsed state transitions to being a distalmost atraumatic end of the funnel shape in the deployed state distal of the catheter body.


In some examples, the distal segment in a collapsed state can be substantially tubular and in the deployed state can include the funnel shape. An air cushion can be formed by the funnel shape between the distal end and the pull ring.


In some examples, the distal segment can be divided into a proximal braid portion and a distal spiral portion.


In some examples, the dilator can include a proximal segment and a distal segment distal of the proximal segment can include a diameter greater than the proximal segment, the distal segment can include a contact element extended radially outward from the distal segment of the dilator and configured to contact and translate proximally the pull ring until being aligned at or adjacent the proximal end of the distal segment of the dilator.


In some examples, the contact element can include an interference fit with the distal end of the distal tip of the catheter body.


In some examples, the distal segment of the dilator can include a greatest diameter at the contact element and decreases from the contact element to the distal end of the distal segment.


In some examples, the distal segment of the dilator can include a greatest diameter at the contact element and tapers from the contact element to a junction between the proximal and distal segments of the dilator.


In some examples, the proximal segment of the dilator being highly flexible or substantially more flexible than the distal segment of the dilator.


In some examples, the dilator can include a substantially flexible segment extending distally of the stiffer distal segment, the substantially flexible segment being a short nose.


In some examples, the proximal segment of the dilator can include a fiber reinforcement system to negate elongation.


In some examples, the dilator can include a proximal segment and a distal segment distal of the proximal segment. The distal segment of the dilator can include a greatest diameter greater than the proximal segment. The distal segment of the dilator can include a distal contact element extended radially outward from the distal segment and configured to contact and translate proximally the pull ring until being aligned at or adjacent the proximal end of the distal segment. A proximal contact element of the dilator can be proximally spaced from the distal contact element and extended radially outward from the distal segment and configured to contact and translate proximally the pull ring, the proximal contact element can include a diameter less than the distal contact element. The pull ring can be connected between the contact elements.


In some examples, the pull ring can be positioned in a gap positioned between the contact elements.


In some examples, the contact element can include an interference fit with the distal end of the distal tip when in the funnel shape of the deployed state.


In some examples, at least one of the contact elements includes a magnetic connector operable to magnetically retract the distal tip to the funnel shape of the deployed state.


In some examples, the proximal segment and/or the distal segment of the dilator can include a substantially thinned wall.


In some examples, the proximal segment can include string-like filaments configured to prevent elongation under tension.


In some examples, the proximal segment of the distal tip can be stiffer than the distal segment.


In some examples, the distal segment can be stiffer than the proximal segment.


In some examples, the distal segment can include a resistance to remain in a substantially tubular shape prior to deployment.


In some examples, the proximal segment and/or the distal segment of the distal tip can include a braided structure.


In some examples, the proximal segment and/or the distal segment of the distal tip can include a memory alloy.


In some examples, the distal segment of the distal tip in a collapsed state can be substantially tubular and in the deployed state can include the funnel shape, an air cushion formed by the funnel shape between the distal end and the pull ring.


In some examples, the dilator can include a proximal segment and a distal segment distal of the proximal segment. The distal segment can include a distal contact element extended radially outward from the distal segment and configured to contact and translate proximally the pull ring until being aligned at or adjacent the proximal end of the distal segment of the distal tip. The pull ring can include a magnetic connector. The proximal end of the distal tip is magnetized configured to attract the pull ring thereby causing the distal tip to retract to the funnel shape.


In some examples, the proximal end of the distal tip and the pull ring are locked together in the deployed state, including, but not limited to, corresponding magnets locked together.


In some examples, the proximal end of the distal tip and the pull ring each include planar mating surfaces.


In some examples, the proximal end of the distal tip and the pull ring each include mating surfaces profiled with ridges and/or interlocking recesses.


In some examples, the proximal end of the distal tip and the pull ring each include mating surfaces tapered for a taper lock interaction.


In some examples, the proximal end of the distal tip and the pull ring each include mating surfaces configured to snap lock together.


In some examples, the pull ring includes a similar diameter to the catheter body such that an abutment is formed between the pull ring and catheter body in the deployed state. The distal tip can extend distally from an inner diameter of the pull ring and around an outer diameter of the pull ring to extend proximally over the catheter body.


In some examples, the distal tip can include a proximal segment and a distal segment extended from the proximal segment. The distal segment of the distal tip can be substantially flexible and include a proximal end positioned on an outer surface of the distal tip. The distal segment of the distal tip can include a pull ring adjacent or immediately distal thereof. The distal tip can be configured for interacting between the pull ring and a distal face of catheter body.


In some examples, the proximal end of the distal segment of the distal tip can be external to the pull ring.


In some examples, the distal tip can be integral with the catheter body. The distal tip can include a proximal segment and a distal segment extended from the proximal segment. The distal segment can be substantially flexible and include a proximal end substantially aligned with a pull ring internal thereto when configured in the funnel shape.


In some examples, the dilator can include a substantially tubular proximal segment and a distal segment distal of the proximal segment. The distal segment of the dilator can include a diameter greater than the proximal segment. The distal segment of the dilator can include a contact element extended radially outward from the distal segment and configured to contact and translate proximally the pull ring until being aligned at or adjacent a distal end of the proximal segment of the distal tip.


In some examples, the contact element can be an outward angled latch.


In some examples, the contact element can be an orthogonally outward latch.


In some examples, the contact element can be distal of the proximal end of the distal segment.


In some examples, a midpoint of the distal segment of the distal tip in a collapsed state transitions to being a distalmost petal tip of the funnel shape in the deployed state distal of the catheter.


In some examples, a midpoint of the distal segment of the distal tip in a collapsed state transitions to being a distalmost flower-like petal tip of the funnel shape in the deployed state distal of the catheter.


In some examples, the dilator can include a proximal segment and a distal segment distal of the proximal segment. The distal segment can include a distal contact element extended radially outward from the distal segment and configured to contact and translate proximally the pull ring until being aligned at or adjacent the proximal end of the distal tip.


In some examples, the dilator can include a proximal contact element tapering proximally from the distal contact element. The proximal contact element can include a diameter less than the distal contact element. In some examples, the distal contact element can be an outwardly extend ring-like member. In some examples, the distal contact element can include a semi-circle shape. In some examples, the distal contact element can be connected to the pull ring.


In some examples, a midpoint of the distal segment in a collapsed state transitions to being a distalmost petal tip of the funnel shape in the deployed state distal of the catheter.


In some examples, a midpoint of the distal segment in a collapsed state transitions to being a distalmost flower-like petal tip of the funnel shape in the deployed state distal of the catheter.


In some examples, the dilator can include a proximal segment and a distal segment distal of the proximal segment. The distal segment can include a greatest diameter greater than the proximal segment and can include a diameter larger than the proximal segment. A distal contact element can include a transition from the distal segment to the proximal segment and configured to contact and translate proximally the pull ring to cause an interference fit with the pull ring to transmit a force to expand the distal tip to the funnel shape.


In some examples, the distal tip is configured to first expand to a substantially conical shape before inverting to form the funnel shape.


In some examples, the proximal segment of the dilator is highly flexible and includes a thin wall.


In some examples, the proximal segment of the dilator is highly flexible and includes longitudinal string-like fibres to prevent it from stretching under tension.


In some examples, upon forming the inverted funnel shape, an interference force between the dilator and the pull ring is incapable of moving the pull ring proximally.


In some examples, the dilator tip can squeeze through the pull ring.


In some examples, the dilator tip is easily retracted through the catheter.


In some examples, the dilator tip can include a proximal segment and a distal segment extended from the proximal segment. The distal segment can be substantially flexible and be at least partially positioned around the proximal segment at least at a proximal end of the distal segment. The distal tip can include a pull ring, which can include an external taper matching an internal taper of the proximal segment such that tapers lock together when forming the funnel shape.


In some examples, the braid extends circumferentially at a mid point of the distal tip to aid in defining a rounded inversion seam.


In some examples, the braid extends from proximal to distal end of the distal tip thereby providing a rounded inversion seam.


In some examples, the braid includes a subset of filaments extended from proximal to middle portions so that the filaments revert to extend back to the proximal portion forming a looped braid pattern, and the remaining filaments extend from a proximal end to a distal end such that a spiral portion is formed distal of the looped subset of filaments.


In some examples, the braid includes filaments extended from proximal to distal portions in a helical configuration.


In some examples, the braid includes an inversion hinge in or around the middle portion.


In some examples, the proximal portion can be relatively stiff. The middle portion can be relatively flexible, and the distal portion can include a flexible helix.


In some examples, the distal tip can include a braid with proximal, middle and distal portions, wherein the distal portion includes sufficient radial force to push the proximal portion radially outwardly while being configured to accommodate various vessel sizes in an atraumatic manner.


In some examples, a method of inverting an expansile catheter in a blood vessel is disclosed. The method can include advancing the catheter to a target site; and retracting, by a dilator at least partially within a lumen of the catheter, a distal tip of the catheter, causing the distal tip to expand and invert to a funnel shape.


In some examples, the method can include restricting, by the funnel shape, flow in the blood vessel.


In some examples, the method can include withdrawing the dilator from the catheter; aspirating through the catheter to stimulate a thrombus into a mouth of the funnel shape; and withdrawing the catheter with the captured thrombus from the patient.


In some examples, the method can include capturing the occlusive thrombus with a mechanical thrombectomy device; and withdrawing the thrombectomy device into the funnel shape of the catheter.


In some examples, the dilator may not be required. In such approaches, the collapsed tip can be corked onto the clot and aspiration suction force can pull the distal end proximally to invert the tip and create the inverted funnel shape during aspiration.


Other aspects and features of the present disclosure will become apparent to those of ordinary skill in the art, upon reviewing the following detailed description in conjunction with the accompanying figures.





BRIEF DESCRIPTION OF THE DRAWINGS

The above and further aspects of this disclosure are further discussed with the following description of the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the disclosure. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation. It is expected that those of skill in the art can conceive of and combining elements from multiple figures to better suit the needs of the user.



FIG. 1A depicts an expansile tip of an expansile catheter in a first configuration with a dilator of this disclosure.



FIG. 1B depicts the expansile tip of the expansile catheter in another configuration with the dilator of FIG. 1A.



FIG. 1C depicts the expansile tip of the expansile catheter in another configuration with the dilator of FIG. 1A.



FIG. 2A depicts the expansile tip of an expansile catheter of FIGS. 1A-1C, deployed to a target location, according to aspects of the present disclosure.



FIG. 2B depicts the expansile tip of an expansile catheter of FIGS. 1A-1C, deployed to a target location, according to aspects of the present disclosure.



FIG. 2C depicts the expansile tip of an expansile catheter of FIGS. 1A-1C, deployed to a target location, according to aspects of the present disclosure.



FIG. 2D depicts the expansile tip of an expansile catheter of FIGS. 1A-1C, deployed to a target location, according to aspects of the present disclosure.



FIG. 3A depicts an expansile tip of an expansile catheter in a first configuration with a dilator of this disclosure.



FIG. 3B depicts the expansile tip of the expansile catheter in another configuration with the dilator of FIG. 3A.



FIG. 4A depicts an expansile tip of an expansile catheter in a first configuration with a dilator of this disclosure.



FIG. 4B depicts the expansile tip of the expansile catheter in another configuration with the dilator of FIG. 4A.



FIG. 5A depicts an expansile tip of an expansile catheter in the deployed configuration with a dilator of this disclosure.



FIG. 5B depicts an expansile tip of an expansile catheter in the deployed configuration with a dilator of this disclosure.



FIG. 5C depicts an expansile tip of an expansile catheter in the deployed configuration with a dilator of this disclosure.



FIG. 6A depicts an expansile tip of an expansile catheter in the deployed configuration with a dilator of this disclosure.



FIG. 6B depicts an expansile tip of an expansile catheter in the deployed configuration with a dilator of this disclosure.



FIG. 6C depicts an expansile tip of an expansile catheter in the deployed configuration with a dilator of this disclosure.



FIG. 7A depicts the expansile tip of an expansile catheter of FIG. 6B, being deployed according to aspects of the present disclosure.



FIG. 7B depicts the expansile tip of an expansile catheter of FIG. 6B, being deployed according to aspects of the present disclosure.



FIG. 7C depicts the expansile tip of an expansile catheter of FIG. 6B, being deployed according to aspects of the present disclosure.



FIG. 8A depicts the expansile tip of an expansile catheter being deployed according to aspects of the present disclosure.



FIG. 8B depicts the expansile tip of an expansile catheter of FIG. 8A, being deployed according to aspects of the present disclosure.



FIG. 8C depicts the expansile tip of an expansile catheter of FIGS. 8A-8B, being deployed according to aspects of the present disclosure.



FIG. 9A depicts an expansile tip of an expansile catheter in the deployed configuration with a dilator of this disclosure.



FIG. 9B depicts the expansile tip in the deployed configuration of FIG. 9A with the dilator removed.



FIG. 10A depicts an expansile tip of an expansile catheter in a first configuration, according to aspects of the present disclosure.



FIG. 10B is a close-up of the expansile tip of FIG. 10A in the deployed configuration, according to aspects of the present disclosure.



FIG. 11A depicts an expansile tip of an expansile catheter in a first configuration with a dilator of this disclosure.



FIG. 11B depicts the expansile tip of the expansile catheter in another configuration with the dilator of FIG. 11A.



FIG. 12A depicts a side view of an expansile tip of an expansile catheter in one configuration according to this disclosure.



FIG. 12B depicts a rear view of the expansile tip of FIG. 12A in another configuration according to this disclosure.



FIG. 12C depicts a side view of the expansile tip of FIG. 12B according to this disclosure.



FIG. 12D depicts a front view of the expansile tip of FIG. 12B according to this disclosure.



FIG. 13 depicts a side view of an expansile tip of an expansile catheter in one configuration according to this disclosure.



FIG. 14A depicts a side view of an expansile tip of an expansile catheter in one configuration according to this disclosure.



FIG. 14B depicts a rear view of the expansile tip of FIG. 14A in another configuration according to this disclosure.



FIG. 14C depicts a side view of the expansile tip of FIG. 14B according to this disclosure.



FIG. 14D depicts a front view of the expansile tip of FIG. 14B according to this disclosure.



FIG. 15A depicts a side view of an expansile tip of an expansile catheter in one configuration according to this disclosure.



FIG. 15B depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 15C depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 16A depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 16B depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 16C depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 16D depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 16E depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 16F depicts a close-up view of the expansile tip of FIG. 15A according to this disclosure.



FIG. 17 is a flow diagram outlining a method of use for the system according to aspects of the present disclosure.





DETAILED DESCRIPTION

The objective of the solution of this disclosure is an invertible, expansile catheter capable of providing both local flow restriction/arrest with a large distal facing mouth and a tailored, highly flexible body section capable of navigating tortuous areas of the vasculature to reach an occlusive clot. Flow restriction and large tipped designs offer substantially greater aspiration efficiency. Such advantages can also be especially beneficial in the case of stroke intervention procedures, where vessels in the neurovascular bed are particularly small and circuitous, and as a result a tailored axial and bending stiffness profile can inhibit kinking and binding. The catheter can also be compatible with relatively low-profile access sheaths and outer catheters, so that a puncture wound in the patient's groin (in the case of femoral access) can be easily and reliably closed. The catheter can also feature internal and/or external low-friction liners, and an outer polymer jacket or membrane disposed around the support structure.


These improvements can lead to safe and more rapid access of a catheter and other devices to complex areas in order to remove occlusions and shorten procedure times. While the description is in many cases in the context of mechanical thrombectomy treatments, the systems and methods may be adapted for other procedures and in other body passageways as well.


Accessing the various vessels within the vascular system, whether they are coronary, pulmonary, or cerebral, involves well-known procedural steps and the use of a number of conventional, commercially-available accessory products. These products, such as angiographic materials, rotating hemostasis valves, and guidewires are widely used in laboratory and medical procedures. When these products are employed in conjunction with the system and methods of this disclosure in the description below, their function and exact constitution are not described in detail.


Referring to the figures, in FIGS. 1A-1C there is illustrated a catheter system 100 for removing an occlusive clot C (shown in FIGS. 2A-2D) from a vessel BV of a patient. System 100 can be an aspiration catheter of traditional construction or can have rapid-exchange (RX) type features, many of which can greatly increase the speed and efficiency of the clot retrieval procedure. In particular, FIGS. 2A-2D illustrate catheter body 50 of catheter 100 deployed to a target blood vessel BV, according to aspects of the present disclosure. System 100 can be actuatable to a deployed state, which is shown in FIG. 1C. A dilator 70 can be positioned at least partially within the lumen 47 of the catheter body 50. A distal end 78 of the dilator 70 can be connected to a distal tip 51 of the catheter body 50. The dilator 70 can be retractable to invert the distal tip 51 and form a funnel shape in the deployed state, as shown with system moving proximally one or more distances D from an initial elongate state of FIG. 1A to deployed in FIG. 1C. While FIG. 1C does show the deployed state, dilator 70 would be fully removed prior to aspiration in order to maximize the flowrate possible through the catheter body of tip 51 and also to allow passage of a microcatheter and stentriever. Dilator 70 may also include a distally protruding microcatheter portion such that a stentriever could be uncovered across the clot during activation of the funnel and removal of the dilator 70.


For an OD of approximately 2 mm catheter body in an M1, the ratio of collapsed OD to deployed funnel OD is contemplated to range between approximately 2.5 mm to 4.0 mm. At the carotid T, the ratio is contemplated to range 4.0 mm to 6.0 mm. Where the ratio is contemplated to range 5.0 to 8.0 mm, the ratio is feasible for ICA vessel placement. Where the ratio is contemplated to range 2.5 to 5.0 mm, the ratio is envisaged to target M1 and Carotid T locations.


In some examples, a ratio between the collapsed OD to funnel OD is dependent on the length of the corresponding catheter tip when collapsed. Preferably, the tip collapsed length can be range between 3 mm and 8 mm (e.g., the distances D in the figures) for expanded ODs of approximately 2.5 mm to 5.0 mm. Yet, in some examples, the ratio can be a function of the diameter the braid is set at and the braid angle.


System 100 can be configured to expand to a wide range of target vessel diameters, such as a carotid terminus (3.2-5.2 mm), a horizontal M1 segment of the Middle Cerebral Arteries (1.6-3.5 mm), and/or the Internal Carotid Artery (ICA, 2.7-7.5 mm). If the catheter system 100 is then retracted from an M1 segment to the ICA (or another route with a proximally increasing vessel inner diameter), the radial force of the tip 50 once in the funnel shape can continue to seal with the vessel across a range of vessel sizes. Further, a tip 50 capable of a range of target vessel diameters can also seal at vessel bifurcations which can have a wider cross-sectional area than the vessel proximal and vessels distal to the bifurcation. Preferably, the tip 51 is inverted to the deployed funnel shape at the treatment location to avoid having to advance a funnel-shaped catheter tip through the vasculature.


The ideal nominal diameter of the catheter system 100 depends on the location of the target clot and/or a diameter of any other catheter through which catheter system 100 is to be delivered. For retrieval of clots in the intracranial vessels of the cerebral vascular bed, where vessel diameters at the M1 locations are commonly around 3 mm, an applicable system can have an outer catheter with an inner diameter of 0.065″ to 0.080″ and an RX clot retrieval catheter with an inner diameter of 0.055″-0.070″. Upon deployment, the maximum diameter of the tip 50 can be a minimum of 2.5 mm (but in some instances up to 8 mm), allowing it to seal against the walls of the vessel and providing a funnel-shape distal mouth as large as the vessel itself. In some instances, the tip 51 can also provide an opening large enough to oppose bifurcations and/or proximal vessel locations. This seal, in combination with a maximized proximal lumen of the disclosed RX system over a conventional catheter, offers benefits in terms of aspiration force at the face of the clot and increased flowrates with a design that utilizes the larger inner diameter of the outer catheter.


In some examples, distal tip 51 can include a proximal segment 55 and a distal segment 52 extended from the proximal segment 55. Segment 52 can be substantially flexible and a proximal end 53 of the distal segment 52 can be extended from the proximal segment 55 and include a pull ring 54 adjacent and/or connected to a distal end 58 of the distal segment 52. Pull ring 54 in this example can be positioned on a proximal face 54 of the distal end inside the distal segment 52. In this respect, segment 52 can be an expandable sheath attached under pull ring 54.


A midpoint of the distal segment 52 in the collapsed state, as in FIG. 1A, can transition to being a distalmost atraumatic end of the funnel shape in the deployed state, as in FIG. 1C, distal of the catheter body 50, as dilator 70 moves proximally a distance D while connected to distal end 58. Distal segment 52 in a collapsed state can be substantially tubular (FIG. 1A) whereas in in the deployed state after proximally moving distances D (FIG. 1B, FIG. 1C) segment 52 can include the funnel shape.


In some examples, the funnel shape formed by the inverted distal segment 52 can include an air cushion 60 formed between the distal end 58 and the pull ring 54. In some examples of the funnel shape, ring 54 can be positioned inside the lumen 47 to form a compression lock therewith thereby securing segment 52 in its expanded, funnel shape. The compression lock can be defined as the interference fit by fitting the ring 54 within lumen 47 whose inner diameter may be slightly less than the outer diameter of ring 54.


In some examples, the distal segment 52 can be divided into a proximal braid portion and a distal spiral braid portion. An elastomeric membrane can be interlaced, coated thereon, or extend over the braid or inverting frame structure. For example, an elastic membrane can follow the contours of the underlying braided strut framework of tip 51. The elastic membrane can at least partially run the length of tip 51. In other examples, tip 51 can be further coated with a lubricious material such as commercially available hydrophilic coatings (e.g., Surmodics, Harland, Biocoat, Covalon) or may include low friction materials or fillers. The membrane can also float over the inverting support structure such that the inverting structure struts can move freely under the membrane. In some examples, the membrane incapsulates the inverting support structure.


In some examples, dilator 70 can include a proximal segment 76 and a distal segment 77 distally extended thereof. Segment 77 can include a diameter greater than the proximal segment 76 and include a contact element 71 extended radially outward to contact and translate proximally the pull ring 54 one or more distances D until being aligned at or adjacent the proximal end 53 of the distal segment 52. In this example, contact element 71 can be a sudden, angled outward transition that creates a contact surface that forms an interference fit with distal end 58 of segment 52.


In some examples, dilator 70 can be solid and/or hollow with a lumen therein. Dilator 70 can include an inner lumen 75 be substantially elongate (e.g. tubular) at its proximal segment 76 and taper radially, outwardly to distal segment 77 with distal end 78 having a larger diameter than the proximal segment 76. This taper can commence at a transition or junction 73 between segments 76, 77. Dilator 70 can be highly flexible proximal to tip 51. Dilator 70 can include one or more fibers as part of its structure that are configured for reinforcement to negate elongation thereof. In some examples, segment 76 can be highly flexible or substantially more flexible than the distal segment 77. The distal segment 77 in some examples can still have adequate flexibility to contort around tortuous vasculature. Any stiff portions required to transmit force to ring 54 can be kept as short as possible to maintain lateral flexibility of the tip 51.


In one example, system 100 can use an aspiration source to capture a clot, as shown in FIGS. 2A-2D. In particular, FIGS. 2A-2D show system 100 being deployed and then aspirating clot C, preferably with dilator 70 fully removed as in FIG. 2D. The main advantage of using dilator 70 as shown and described is that it can be removed after inversion of the tip such that the full cross-sectional area of catheter 50 can be used to maximize flow rate and force on the clot C through catheter body 50 when in the funnel shape, as shown. As also shown in FIGS. 2A-2D, the funnel shape formed by tip 51 being expanded can seal with the walls of the blood vessel BV or the seal or seals can be selectively activated (e.g., by moving dilator 70 proximally or distally).


Tip 51 once expanded can include a large, atraumatic mouth for efficient aspiration. Tip 51 can include kink-resistant characteristics to aid in advancing it to the target location. It can therefore have multiple configurations, or be fabricated from multiple materials, as discussed herein, so as to maintain lateral flexibility but avoid expanding or kinking in compression. The large distal mouth of tip 51 shown in FIGS. 2A-2D can offer improved performance over conventional fixed-mouth designs, which can be hindered by having firm, fibrin-rich clots lodge in the tip and/or by having softer portions of the clot shear away. It is less likely for clots to become lodged in the tubular section of the disclosed invertible, expansile tip 51 due to the progressive compression of the clot upon entry to the reducing funnel shape.


Struts of the tip 51 can be formed from Nitinol or another shape-memory material with sufficient elastic strain capacity such that the elastic limit would not be exceeded when the tip is constrained and delivered in the collapsed configuration within an outer catheter or during expansion to invert to a funnel shape. The struts can be heat set expanded only to promote inversion at a predetermined location, said expanded area being restrained by an outer membrane covering. Actively inverting in this respect the frame then pushes the membrane outwardly by increasing the radial force of the frame. In another case, the framework can be constructed from wire, allowing a non-superelastic material like a stainless-steel alloy to be employed, since the wires would be free to move independent of one another. It is appreciated that a framework of tip 51 constructed of wire using superelastic or shape memory materials can also be envisaged, such a device offering improved torque and durability characteristics. In another case, a framework of tip 51 can be laser cut or formed with wire from a non-superelastic or shape memory material that accommodates strain by including cells or bends, with a lower degree of strain required to move from a collapsed state for delivery to an expanded state for clot retrieval. For example, the framework can include additional cells, longer cell struts, and/or lower cell angles to reduce strain requirements.



FIGS. 3A-3B depicts another invertible, expansile tip 251 going from a first configuration, shown in FIG. 3A, with dilator 270 and then a close-up of the funnel-shape, deployed configuration of tip 251 in FIG. 3B without dilator 270. While not shown, dilator 270 could be included in FIG. 3B as needed or required. It is understood that similar reference numbers examples discussed throughout this disclosure indicate identical or functionality similar elements. With that, dilator 270 can include inner lumen 275 with proximal segment 276 and distal segment 277 terminating in distal end 278 distal of the proximal segment 276. Dilator 270 can include distal contact element 271 extended radially outward from the distal segment 277. Element 271 can be configured to contact and translate the pull ring 254 until being aligned at or adjacent the proximal end 258 of the distal segment 252. Dilator 270 may also include a sudden, angled outward transition (e.g., element 271 here being substantially orthogonal to the outer surface of dilator 270) to form a contact surface that forms an interference fit with distal end 258 of segment 252. Dilator 270 can also have a proximal contact element 273 proximally spaced from the distal contact element 271 and similarly extended radially outward from the distal segment 277. In some examples, a groove can be defined between elements 271, 273 in which the pull ring 254 can be positioned or otherwise connected. In this respect, opposed faces of the space or groove between elements 271, 213 can be planar or otherwise conform to the shape of ring 254. In some examples, element 271 can urge or otherwise couple to end 258 while element 273 can urge or otherwise couple to ring 254. In some examples, element 273 can include a diameter less than element 271, or vice versa. From element 271 to distal end 278, dilator 270 can taper to a smaller diameter.


As in system 100, an interference fit can be provided in catheter body 250 between distal end 258 of the distal tip 251 when in the funnel shape of the deployed state. In some examples, at least one of the contact elements 271, 273 can include a magnetic connector operable to magnetically retract the distal tip 251 to the funnel shape of the deployed state. In so doing, the magnetic coupling therein can facilitate the actuation of tip 271 into the inverted, funnel-shape of the deployed state. Segment 276 and/or the segment 277 can include a substantially thinned wall. Preferably, going from segment 276 to segment 277, dilator can include a relatively thin wall proximal to tip for optimum flexibility.


Segment 276 in some examples can include string-like filaments configured to prevent elongation under tension. With respect to tip 251, its proximal segment 255 can be stiffer than the distal segment 252. However, this example is not so limited and instead segment 252 can be stiffer than the proximal segment 255. In some examples, segment 252 can include a resistance or bias to remain in its substantially tubular shape prior to deployment, as in FIG. 3A. Proximal segment 255 and/or distal segment 252 can also include a braided structure, similar to segments 152, 155. For examples, segments 252, 255 can be constructed from a framework of struts that include a memory alloy. Similar to segment 52, segment 252 can be divided into a proximal braid portion and a distal spiral braid portion as well include one or more elastomeric coating(s) or membrane(s). The braid and spiral portions of this example can be created, for example, by finishing the ends of the clockwise braid wires at a midpoint between the ends of the counterclockwise braid wires such that the counterclockwise braid wires form a spiral past this point. In some examples, this can be achieved by cutting the clockwise wires of a standard braid on a circumferential plane at a location between the ends of the braid. In another example, clockwise braids can be looped to extend proximally such that a denser proximal braid is paired with a distal spiral portion.



FIGS. 4A-4B depicts another invertible, expansile tip 351 of catheter 350 going from a first configuration, shown in FIG. 4A, with dilator 370 and then a close-up of the funnel-shape, deployed configuration in FIG. 4B, after dilator 370 has been retracted to invert tip 351 to the funnel-shape. In this instance, proximal segment 355 of tip 351 can include a distal end 353 that can include a magnetic element capable of coupling with corresponding ring 354, which in turn can be magnetized. Ring 354 as shown can be configured to magnetically couple with end 353 so tip 351 can maintain the inverted, funnel shape shown in FIG. 4B. In some examples, ring 354 and/or end 353 can be made from a ferrous metal such that one is attracted to the other. Alternatively, both features are magnetic such that the south pole of one engages with the north pole of the other to form a stronger engagement than if a ferrous metal was used. In yet another embodiment, dilator 370 can include magnetic features to engage with the pull ring 354 to provide sufficient force to invert tip 351 to its inverted, funnel-shape.


In some examples, dilator 370 can include inner lumen 575, distal segment 377 terminating in distal end 278 distal of the proximal segment 376, with each including similar diameters. Contact element 371 of dilator 370 can be a distal end of a notch or gutter or groove or recess of dilator whereas contact element 372 can be the proximal end of the same notch or gutter or groove or recess. In some examples, element 371 can be magnetic so as to grip ring 354 (e.g., by constructing ring 354 out of one or more ferrous materials), and pull ring 354 proximally during retraction of the dilator 370. Ring 354, which can be coupled to end 358, can be positioned therebetween respective to said notch or gutter or groove or recess and/or therearound. As arranged, distal segment 377 translate pull ring 354 until being aligned at or adjacent the proximal end 358 of the distal segment 352 thereby inverting segment 352 to form the atraumatic funnel-shape of FIG. 4B. In some examples, the proximal end 353 of the distal tip 351 and the pull ring 354 can be locked together in the deployed state by the corresponding magnetic coupling therebetween. The proximal end 353 of the distal tip 351 and the pull ring 354 can each include planar mating surfaces or mating surfaces profiled with ridges and/or interlocking recesses. For example, mating surfaces can be tapered for an interlocking taper lock interaction. In other examples, mating surfaces can be configured to snap lock together.



FIG. 5A depicts another invertible, expansile tip 451 of catheter 450 with dilator 470. Tip 451 can include proximal segment 455 and distal segment 452 extended from the proximal segment 455 and being substantially flexible. A proximal end 453 of the distal segment 452 can be positioned on an outer surface of the distal tip 451. Similar to previously described tips, a pull ring 454 can be adjacent or immediately distal of segment 455 so ring 454 can be used to pull and cause segment 452 to invert to the funnel-shape of FIG. 5A. In some example, proximal end 453 of the distal segment 452 can be external to the pull ring 454. Aligning ring 454 in this respect and attaching proximal end 453 as shown to the OD of catheter 450 and position membrane structure attached to distal face of pull ring. In turn, this attachment allows membrane to smoothly taper distally when inverted.



FIG. 5B depicts another invertible, expansile tip 551 of catheter 550 with dilator 570 of this disclosure. Distal tip 551 as shown can be integral with the catheter body 550, including segment 555 being integral with segment 552. Dilator 570 of this example can also include a greatest diameter at or around contact element 573, which here can be an outward bulge or ring-like extrusion configured to be arranged internal to ring 554 and form an interference fit with element that distally tapers from element 573. As shown, ring 554 fits under catheter body 550, the proximal face of membrane structure is in line with or integral with distal face of catheter body 550, and the membrane structure is attached under pull ring 554. In turn, this attachment allows membrane to smoothly taper distally when inverted.



FIG. 5C depicts another invertible, expansile tip 651 of catheter 650 in the deployed configuration with dilator 670. As shown, dilator 670 can include a distal segment 677 distal of the proximal segment 676 with a diameter greater than the proximal segment 676. The change in diameter can be gradual to form an elliptical or otherwise curved shape. Distal segment 677 can include a contact element 671 extended radially outward from the distal segment 677 and configured to contact and translate proximally the pull ring 654 until being aligned at or adjacent a distal end of the proximal segment 655. Element 671 as can be seen can be an outward angled latch. For example, element 671 as shown can include be angled distally so as to form an acute angle between it and the outer surface of dilator 670. This latch in turn can prevent the distal end of segment 652 from disengaging therefrom in the funnel-shape, as shown.



FIG. 5C depicts another invertible, expansile tip 651 of catheter 650 in the deployed configuration with dilator 670. As shown, dilator 670 can include inner lumen 675, a distal segment 677 with distal end 678 distal of the proximal segment 676 with a diameter greater than the proximal segment 676. The change in diameter can be gradual to form an elliptical or otherwise curved shape. Distal segment 677 can include a contact element 671 extended radially outward from the distal segment 677 and configured to contact and translate proximally the pull ring 654 until being aligned at or adjacent a distal end of the proximal segment 655. Element 671 as can be seen can be an outward angled latch. For example, element 671 as shown can include be angled distally so as to form an acute angle between it and the outer surface of dilator 670. This latch in turn can prevent the distal end of segment 652 from disengaging therefrom in the funnel-shape, as shown.



FIG. 5C depicts another invertible, expansile tip 651 of catheter 650 in the deployed configuration with dilator 670. As shown, dilator 670 can include inner lumen 675, a distal segment 677 with distal end 678 distal of the proximal segment 676 with a diameter greater than the proximal segment 676. The change in diameter can be gradual to form an elliptical or otherwise curved shape. Distal segment 677 can include a contact element 671 extended radially outward from the distal segment 677 and configured to contact and translate proximally the pull ring 654 until being aligned at or adjacent a distal end of the proximal segment 655. Element 671 as can be seen can be an outward angled latch. For example, element 671 as shown can include be angled distally so as to form an acute angle between it and the outer surface of dilator 670. This latch in turn can prevent the distal end of segment 652 from disengaging therefrom in the funnel-shape, as shown.


Element 671 is not so limited, however, and can instead by substantially orthogonal with respect to the outer surface of dilator 670. Element 671 may also be distal of the proximal end 653 of segment 652, whereby end 653 can be positioned on an outer surface of segment 655. In some examples, a midpoint of the distal segment 652 in a collapsed state transitions to being a distalmost petal tip of the funnel shape in the deployed state distal of the catheter 650. System 600 in this respect can include one continuous petal or a plurality of radially separated distalmost flower-like petal tips that form the funnel shape. In other examples, the funnel-shape of system 600 can be more pointed, or less atraumatic than the rounded funnel-shapes of FIGS. 5A-5B.



FIG. 6A depicts another invertible, expansile tip 751 of catheter 750 in the deployed configuration with a dilator 770 of this disclosure. As shown, contact element 771 of dilator 770 is distal of and attached to tip 751 and provides a relatively smooth transition for clot capture and/or use of a stentriever therein. By arranging dilator 770 as shown with respect to tip 751, the inner diameter of system 700 being reduced on account of distal end 758 of segment 752 being positioned at least partially inside the inner diameter of system 700. Advantageously, the proximal face of pull ring 754 abuts the distal face of the catheter body 750 and the membrane/framework can be attached under the pull ring 754. In this example, the proximal membrane structure is attached to the OD of catheter 750 which allows the membrane to smoothly taper distally when inverted.



FIG. 6B depicts another invertible, expansile tip 851 of catheter 850 in the deployed configuration with a dilator 870 of this disclosure. As shown, contact element 871 of dilator 870 is distal of and attached to tip 851. Here, since end 858 of segment 852 is coaxial with segment 855 in the deployed, funnel-shape, the inner diameter between segments 855, 852 is substantially similar, if not equivalent. As shown, tip 851 can also include a relatively sharper edge in the funnel-shape, as compared to tip 751. Here, advantageously the proximal face of ring 854 abuts the distal face of the catheter body 850 and the membrane/framework is attached to the distal face of ring 854. Moreover, this causes a sharper inversion of funnel and the proximal membrane structure attached to an OD of catheter 750.



FIG. 6C depicts another invertible, expansile tip 951 of catheter 950 in the deployed configuration with a dilator 970 of this disclosure. As shown, contact element 971 of dilator 970 is distal of and attached to tip 951. In particular, distal contact element 971 extended radially outward from the distal segment 977 and configured to contact and translate proximally the pull ring 954 until being aligned at or adjacent the proximal end 953 of the distal tip 951. A proximal end face of element 971 can be arranged to contact ring 954, which can be on a distal face of distal end 958 of segment 952. Here the proximal face of ring 954 abuts the distal face of the catheter body 950 and the membrane/framework is attached to the distal face of ring 954 and a relatively sharper inversion of funnel results.


As shown, end 958 can have a biased curve that facilitates contact between ring 954 and end 958. In the funnel-shape configuration shown, the curve can extend proximally before returning distally to urge ring 954 to couple with the proximal face of element 971. In some examples, element 971 can include or be an outwardly extend ring-like member. Element 971 can also include a semi-circle shape.



FIGS. 7A-7C illustrates tip 851 but with a modified, sharper funnel-shape, previously described in FIG. 6B, transitioning from the collapsed, tubular state of FIG. 7A to the deployed, funnel-shape of FIG. 7C. In particular, dilator 870 is seen coupled to ring 854 at its respective contact element. FIG. 7B shows dilator 870 having been retracted a first distance causing segment 852 to initiate its expansion as its midsection begins inverting. FIG. 7C shows ring 854 having been proximally translated by dilator 870 until contacting the distal face of segment 855. In turn, segment 852 is completely inverted to the funnel-shape. Here, ring 854 has a similar diameter to segment 855 such that an abutment is formed between the ring 854 and segment 855 in the expanded state. Advantageously, this minimal difference in inner and outer diameters between the proximal and distal ends of catheter 850 optimizes its relatively low outer profile and large inner diameter.



FIGS. 8A-8C illustrates another expansile, invertible tip 1051 of catheter 1050 of this disclosure being deployed by being inverted in connection with dilator 1070, according to aspects of the present disclosure. In particular, tip 1051 is shown transitioning from the collapsed, tubular state of FIG. 8A to the deployed, funnel-shape of FIG. 8C. A proximal face of element 1071 is coupled to ring 1054. FIG. 8B shows dilator 1070 having been retracted a first distance causing segment 1052 to initiate its expansion as its midsection begins inverting. In the state of FIG. 8B, segment 1052 can include a generally conical shape before inverting. FIG. 8C shows ring 1054 having been proximally translated by dilator 1070 until be arranged proximate the distal face of segment 1055 (e.g., here, internal to segment 1055). In turn, segment 1052 is completely inverted to the funnel-shape shown in FIG. 8C. Ring 1054 can have a diameter to less than an inner diameter of segment 1055 such that an abutment is formed between the ring 1054 and the inner surface of segment 1055 in the expanded state.


In some examples, segment 1077 of dilator 1070 can be ultra soft to provide sufficient interference with pull ring 1054 to transmit a radial force sufficient to cause segment 1052 to expand and invert, as shown between FIGS. 8A-8C. In some examples, segment 1076 can be highly flexible so that it does not contribute significantly to stiffness of system. To achieve this, segment 1076 can include a relatively thin wall and may include longitudinal string-like fibers to prevent it from stretching under tension.


In some examples, once the inverted funnel shape shown in FIG. 8C has been formed, the interference force between the dilator 1070 and ring 1054 can be insufficient to move ring 1054 more proximally and the tip of dilator 1070 (e.g., segment 1077) squeezes through ring 1054. As segment 1077 is sized to have a small clearance with the lumen of segment 1055, segment 1077 can be easily retracted through the catheter system 1000. In some examples, dilator 1070 can be re-advanced to push ring 1054 distally and un-invert the funnel-shape to a collapsed, tubular sheath of FIG. 8A. In some examples, though not shown, a second stiffer dilator may be supplied for the purpose of collapsing tip 1051, once inverted and expanded within a blood vessel, where the first dilator 1070 may be present.



FIGS. 9A-9B illustrate another expansile, invertible tip 1151 of catheter 1150. In particular, FIG. 9A shows tip 1151 with dilator 1170 in the expanded, funnel-shape configuration. FIG. 9B shows tip 1151 in the same configuration but with dilator 1170 having been retracted and removed from tip 1151. Here, the distal face of element 1171 is coupled to the proximal face of end 1158 so that tip 1151 is compressed through ring 1154. In turn, an inner diameter of end 1158 is coupled to ring 1154. In this example, coupling end 1158 to ring 1154 as described and shown allows tip 1151 to form a gradual smooth curve for entry of aspirated clot and or stent retriever devices. Moreover, ring 1154 being sized smaller than main catheter body inner diameter of segment 1155 allows for the pull ring 1054 to wedge or lock in position as segment 1177 of dilator 1170 compresses through it.



FIGS. 10A-10B illustrates tip 1251, according to aspects of the present disclosure, whereby FIG. 10A shows the tip 1251 when extended in the tubular configuration and FIG. 10B is a close-up of tip 1251 ring 1254 has been retracted to cause segment 1252 to expand and invert to the funnel shape. Ring 1254 can include an external taper that matches an internal taper 1259 positioned at a distal end of segment 1255. As shown more clearly in in FIG. 10B which shows the closed up of the coupled tapers, the corresponding tapers can couple and/or lock together. While only tapered surfaces are shown in FIGS. 10A-10B, it is contemplated that other interlocking surfaces can be used as needed or required.



FIGS. 11A-11B depicts another expansile tip 1351 of catheter 1350 going from a first, tubular configuration in FIG. 11A with dilator 1370 and then to the expanded, inverted funnel-shape, deployed configuration of FIG. 11B. Dilator 1370 can include a contact element 1371 that includes the greatest diameter of dilator 1370 and then progressively, distally tapers therefrom for gradual radial compression of clot. Here, ring 1354 can include a similar diameter to the diameter of segment 1355 such that an abutment therebetween can prevent ring 1354 from moving proximally into the lumen of segment 1355, as shown in FIG. 11B. Distal end 1358 of segment 1352 is attached within an inner diameter of ring 1354, which provides the interference fit between end 1358 and/or ring 1354 with element 1371 of dilator 1370. Advantageously, in this example there is less of a difference in inner diameter between segment 1355 and ring 1354 such that clots can be less restricted from entering the lumen of segment 1355.


Further, by folding segment 1352, as shown, to extend distally from the inner diameter of ring 1354 and reverting to extend proximally over the outer diameter of ring 1354, segment 1353 can expand and invert to form a rounded feature for atraumatic funnel configured to interact and seal with a vessel wall.


If tip 1351 were manufactured to be stiff, it would form too large a round profile and have the potential of kinking when collapsed for delivery through an outer balloon guide or long guide sheath. Kinking can also prevent tip 1351 from forming a gradual taper in the deployed, funnel-shape configuration and may form a snag point for stentrievers during retraction in the catheter lumen. Therefore, configuring tip 1351 with a flexible portion can allow it to first form a soft compressible rounded feature in the collapsed configuration that will recover to form a progressive taper extending distally form the inner diameter of ring 1354 to aid in compression of clot during aspiration and to provide an unhindered path for collapsing a stentriever during retraction into the catheter lumen.



FIG. 12A depicts an example construction of one expansile, invertible tip 1451, which can include a braid with proximal 1447, middle 1445, and distal 1443 segments. Middle segment 1445 can include filaments that extend from proximal to a transition point with distal segment 1443, then they revert to extend back proximally forming a braid pattern. Distal segment 1443 can include filaments that extend from proximal to distal in a helical configuration and/or can include sufficient radial force to push proximal segment 1447 radially outwardly while being conformable to accommodate various vessel sizes in an atraumatic manner. A helical pattern can allow for a wider range of vessel size range than a braid as the helical wires will create a spiral pattern that can adjust more easily than a braid pattern. Distal segment 1443 can extend circumferentially at or around the transition between segments 1445, 1443 to aid in defining a less rounded inversion seam at the vessel wall.



FIGS. 12B-12D depicts views of tip 1451 once expanded and inverted to the funnel shape, according to this disclosure. In particular, FIG. 12C is a side plane view of tip 1451 with an example coating (though a coating is not necessarily required) whereas FIG. 12D is a front plan view of segment 1451 and FIG. 12B is a rear plan view of segment 1451. As shown in FIG. 12D, segment 1443 and its helical configuration can convert segment 1443 to spiral during inversion. As is also evident in FIG. 12C, along the lower dashed lines depicts the inversion seam of a sharper inversion seam design in comparison to a rounded inversion seam that can interact with the vessel wall during use. FIG. 12B shows segments 1447 and 1445 which form the braid's integrity and provide an inversion hinge at the transition point between segments 1445, 1443. Though not shown, it is contemplated that a coating or membrane as described in this disclosure could be used with tip 1451 as needed or required.



FIG. 13 depicts an example construction of one expansile, invertible tip 1551, which can include a braid with proximal 1547, middle 1545, and distal 1543 segments, whereby the braid of tip 1551 may extend from proximal to distal end. Tip 1551 can provide a more rounded inversion seam that can interact with the vessel wall during use.



FIG. 14A depicts an example construction of one expansile, invertible tip 1651, which can include a braid with proximal 1647, middle 1645, and distal 1643 segments. Segment 1639 is proximal of segment 1647 and portion 1641 represents a transition between each segment. Segment 1647 can be relatively stiff, segment 1645 can be relatively flexible, and segment 1643 can include a helical configuration with respect to its filaments. Middle segment 1645 can in turn be configured to distribute the radial force over a larger region during the inversion step of tip 1651. Middle segment 1645 being relatively flexible at the mid-section can also lower structure inflection forces during inversion especially with the added constraints of a low profile vessel, thus reducing radial force exerted by the structure and potential vessel trauma.



FIGS. 14B-14D depicts views of tip 1651 once expanded and inverted to the funnel shape, according to this disclosure. In particular, FIG. 14C is a side plane view of tip 1651 whereas FIG. 14D is a front plan view of segment 1651 and FIG. 14B is a rear plan view of segment 1651. As shown in FIG. 14D, segment 1543 and its helical configuration can convert segment 1543 to spiral during inversion. As is also evident in FIG. 14C, the inversion seam of the rounded lower corners segment 1645 can interact with the vessel wall during use. FIG. 14B shows segments 1647 and 1645 which form the braid's integrity and provide an inversion hinge at the transition point between segments 1645, 1643. An inversion hinge can be applied by heat setting the filaments to have a larger diameter at the center than the proximal and distal ends to promote inflection, the membrane having sufficient resistance to expansion to hold the enlarged diameter in a substantially tubular shape in line with proximal and distal segments in the collapsed configuration. This can be done with a non-shape memory material by using an oversized braid and reducing the distal and proximal diameters through attachment means to the distal pull ring and proximal catheter body respectively (e.g., reflowing jacket material, adhesive or by a restraining ring). Though not shown, it is contemplated that a coating or membrane as described in this disclosure could be used with tip 1651 as needed or required.



FIGS. 15A-16F depicts views of an expansile, invertible tip 1751 according to this disclosure. In FIG. 15A, tip 1751 can include a braided construction with segments 1755 and 1752. Segment 1752 can include a proximal portion 1751 and a distal portion 1759, each with a braid pattern (e.g., the same pattern or a different pattern). A transition portion 1753 can be positioned between segments 1755 and 1752. In some examples of tip 1751, braid wires can loop around ring 1754 to allow rotation of the braid about ring 1754 during inversion, which can facilitate complete inversion of the distal segment 1752. FIG. 15A is denoted strictly for illustrative purposes sections A, B, C. It is understood that braided wires can loop from A to C to A. However, segment 1751 is not so limited and braided wires can also loop from A to B to A. In other examples, braided wires can loop from A to B to A to C to A. In other examples, braided wires can loop from A to C, as well as any combination of these various braided wire loop configurations. In some examples, at least one braid wire of tip 1751 can be twisted just proximal of ring 1754 to hold ring 1754 in place.


Turning to FIG. 15B, a close-up of tip 1751 is shown in the expanded, inverted funnel-shape configuration. Here, it can be seen that segment 1752 has been inverted and expanded as ring 1754 has been translated proximally, as in previous example distal tips of this disclosure. FIG. 15C is a similar view of FIG. 15B, but with the mandrel and/or dilator removed and leaving tip 1751 alone in the expanded, inverted funnel-shape configuration.



FIG. 16A is a close-up view of section A of FIG. 15A showing braided wires as previously described. FIG. 16B is a close-up view of section B of FIG. 15A showing braided density or PPI change as previously described. FIG. 16C is a close-up view of section C of FIG. 15A showing braided wires looped around pull ring as previously described. FIG. 16D is a close-up cross-section view of section C of FIG. 15A along center line with an example dilator 1770 coupled with ring 1754. As shown, dilator 1770 has circumferential ribs to grip pull ring 1754. FIG. 16E is a close-up cross-section view of section C of FIG. 15A along center line with another example dilator 1770 coupled with ring 1754, whereby dilator 1770 includes abutment features that fold distally to aid radial compression to squeeze through ring 1754 after reaching a predetermined force. FIG. 16F is a close-up perspective view of section C of FIG. 15A showing braided wires looped and coupled with ring 1754, as previously described. The filaments in the present example can extend proximal to distal and can be looped back at the distal end. Ring 1754 can be threaded through the looped ends such that when inverted the looped filaments rotate about ring 1754 to invert the outward face to face radially inwardly and thereby form a distal facing funnel, as shown.


Visibility during deployment of any of the herein disclosed catheter systems can be aided by adding alloying elements (such as palladium, platinum, gold, etc.), by the application of a radiopaque compound, or through the placement of radiopaque markers on one or more of the catheters and devices. Suitable practices are frequently used in connection with other devices and implants and are well known in the art. For example, a radiopaque compound can be incorporated on a cover can be incorporated in the distal tip, or one or more radiopaque markers can be added at, on, and/or adjacent the distal end of the tip. Additionally, one or more of the braid wires may include DFT wire comprising a platinum core (for radiopacity) with NiTi outer layer. With such markers, the physician will be able to visually confirm that the mouth has fully inverted and expanded to the vessel wall.


The aspiration source used in the catheter systems of this disclosure can be a manual syringe or a small-displacement vacuum pump and aspiration directed to the distal tip of any of the herein disclosed catheter systems. Effective aspiration can be accomplished by the sealing action of the inverted, funnel shape of the distal tip with the vessel walls, the interior walls of an outer catheter, and/or through the use of a flow restrictor/seal. In some instances, however, dislodging or fully retrieving a clot with any of the heretofore catheter systems using aspiration alone is not possible. In this respect, it is contemplated that a thrombectomy device can be used with the catheter systems of this disclosure and can be any of a number of commercially available products which can be supplied with or separate from the aspirating clot retrieval catheter. Using a thrombectomy device in conjunction with an expanding mouth catheter system of this disclosure has several benefits to increase the likelihood of first-pass success. The thrombectomy device can support the lumen of the vessel during aspiration such that it will be less likely to collapse under negative pressure, and the thrombectomy device will hold the clot together should the clot comprise an array of stiff and soft portions that may otherwise fragment. The thrombectomy device can also allow the user to pinch a clot that otherwise would not fully enter the lumen of the clot retrieval catheter between the catheter tip and thrombectomy device. A pinched clot will be less likely to dislodge from the clot retrieval catheter as the clot retrieval catheter, clot, and thrombectomy device are retracted as one through the vasculature and outer catheter.



FIG. 17 is a flow diagram each comprising method steps for performing a procedure with one system of this disclosure. The method steps can be implemented by any of the example systems, devices, and/or apparatus described herein or by a means that would be known to one of ordinary skill in the art.


Referring the method 1700 outlined in FIG. 17, step 1710 includes advancing any catheter of this disclosure to a target site. Step 1720 includes retracting, by a dilator at least partially within a lumen of the catheter and preferably removing the dilator to maximize aspiration flow rate and force on a clot that is retracted into the catheter, a distal tip of the catheter, causing the distal tip to expand and invert to a funnel shape.


In some examples of method 1700, the dilator can be withdrawn and aspiration can then be applied through the catheter, depending on how the user has deployed the flow restrictions and/or seals, to stimulate the clot into the mouth of the catheter. If aspiration alone is insufficient to dislodge and capture the thrombus or if additional grip on the clot is desired during initial aspiration and dislodgement, a microcatheter with a mechanical thrombectomy clot retrieval device can be advanced to the target. The mechanical thrombectomy device can then be deployed to capture the clot using any method commonly known in the art. Aspiration can continue during the entirety of this step to prevent blood reflux and maintain a tight grip on the clot, or at intervals chosen by the user. In some examples, aspiration and pulling of the clot with a stent retriever may be optimal to increase the chances of first pass success.


In some examples of method 1700, the captured clot and clot retrieval catheter can be withdrawn from the patient or the clot retrieval catheter can be left in place to maintain access as the mechanical thrombectomy clot retrieval device is withdrawn with the clot from the patient. If the clot is observed in the aspiration source and/or thrombectomy device and flow is not blocked in the clot retrieval catheter, this step can also involve carefully injecting contrast under low pressure through the system using known techniques to determine if the vessel is patent. If the vessel is patent, the clot retrieval catheter can be removed. If a blockage remains, additional passes of aspiration, thrombectomy or a combination of these may be repeated until the vessel is patent.


The disclosure is not necessarily limited to the examples described, which can be varied in construction and detail. The terms “distal” and “proximal” are used throughout the preceding description and are meant to refer to a positions and directions relative to a treating physician or user. As such, “distal” or “distally” refer to a position distant to or a direction away from the physician. Similarly, “proximal” or “proximally” refer to a position near to or a direction towards the physician. Furthermore, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.


As used herein, the terms “about” or “approximately” referring to any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values±20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 99%.


In describing example embodiments, terminology has been resorted to for the sake of clarity. It is intended that each term contemplates its broadest meaning as understood by those skilled in the art and includes all technical equivalents that operate in a similar manner to accomplish a similar purpose without departing from the scope and spirit of the disclosure. It is also to be understood that the mention of one or more steps of a method does not preclude the presence of additional method steps or intervening method steps between those steps expressly identified. Some steps of a method can be performed in a different order than those described herein without departing from the scope of the disclosed technology. Similarly, it is also to be understood that some of the method steps may be omitted.


The mention of one or more components in a device or system does not preclude the presence of additional components or intervening components between those components expressly identified. For clarity and conciseness, not all possible combinations have been listed, and such modifications are often apparent to those of skill in the art and are intended to be within the scope of the claims which follow.

Claims
  • 1. A catheter system actuatable to a deployed state, comprising: a catheter body comprising a lumen; anda dilator positioned at least partially within the lumen, a distal end of the dilator releasably connected to a distal tip of the catheter body, the dilator being retractable to expand and invert the distal tip such that the distal tip forms a funnel shape in the deployed state;the distal tip comprising: a proximal segment; anda distal segment extending from the proximal segment, the distal segment being substantially flexible, the distal segment further comprising a proximal end and a distal end, the proximal end comprising a first mating surface;a pull ring adjacent to the distal end of the distal segment, the pull ring comprising a second mating surface,wherein the first mating surface and the second mating surface are configured to snap lock together.
  • 2. The system of claim 1, wherein a midpoint of the distal segment in a collapsed state transitions to being a distalmost atraumatic end of the funnel shape in the deployed state distal of the catheter body.
  • 3. The system of claim 1, the distal segment in a collapsed state being substantially tubular and in the deployed state comprising the funnel shape, an air cushion formed by the funnel shape between the distal end of the distal segment and the pull ring.
  • 4. The system of claim 1, the distal segment divided into a proximal braid portion and a distal spiral portion.
  • 5. The system of claim 1, the dilator comprising a proximal dilator segment;a distal dilator segment distal of the proximal dilator segment comprising a diameter greater than a diameter of the proximal dilator segment, the distal dilator segment comprising a contact element extended radially outward from the distal dilator segment and configured to contact and translate proximally the pull ring until the pull ring is aligned at or adjacent to the proximal end of the distal segment extended from the proximal segment of the distal tip.
  • 6. The system of claim 5, the contact element comprising an interference fit with the distal end of the distal tip of the catheter body.
  • 7. The system of claim 5, the distal segment of the dilator comprising a greatest diameter at the contact element and decreases from the contact element to the distal end of the distal segment.
  • 8. The system of claim 5, the distal segment of the dilator comprising a greatest diameter at the contact element and tapers from the contact element to a junction between the proximal segment of the dilator and the distal segment of the dilator.
  • 9. The system of claim 5, the proximal segment of the dilator being highly flexible or substantially more flexible than the distal segment of the dilator.
  • 10. The system of claim 9, further comprising: a substantially flexible segment extending distally of the stiffer distal segment, the substantially flexible segment being a short nose.
  • 11. The system of claim 5, the proximal segment of the dilator comprising a fiber reinforcement system to negate elongation.
  • 12. The system of claim 1, wherein the proximal end of the distal tip and the pull ring are locked together in the deployed state.
  • 13. The system of claim 1, the distal tip being configured to first expand to a substantially conical shape before inverting to form the funnel shape.
  • 14. The system of claim 1, the distal tip comprising a braid comprising proximal, middle, and distal portions, wherein the braid comprises filaments extended from the proximal portion to the distal portion in a helical configuration, wherein the distal portion comprises sufficient radial force to push the proximal portion radially outwardly while being configured to accommodate various vessel sizes in an atraumatic manner.
  • 15. A method of inverting an expansile catheter in a blood vessel, comprising: advancing the catheter to a target site;retracting, by a dilator at least partially within a lumen of the catheter, a pull ring approximate a distal tip of the catheter, causing the distal tip to expand and invert to a funnel shape, the pull ring and a proximal end of the distal tip each comprising mating surfaces configured to snap lock together.
  • 16. The method of claim 15, further comprising: restricting, by the funnel shape, flow in the blood vessel.
  • 17. The method of claim 15, further comprising: withdrawing the dilator from the catheter;aspirating through the catheter to stimulate a thrombus into a mouth of the funnel shape; andwithdrawing the catheter with the thrombus from a patient.
  • 18. The method of claim 15, further comprising: capturing an occlusive thrombus with a mechanical thrombectomy device; andwithdrawing the mechanical thrombectomy device into the funnel shape of the catheter.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims the benefit of U.S. Provisional 62/898,864, filed Sep. 11, 2019, the contents which are herein incorporated by reference.

US Referenced Citations (762)
Number Name Date Kind
4243040 Beecher Jan 1981 A
4324262 Hall Apr 1982 A
4351342 Witta et al. Sep 1982 A
4575371 Nordqvist et al. Mar 1986 A
4719924 Crittenden et al. Jan 1988 A
4738666 Fuqua Apr 1988 A
4767404 Renton Aug 1988 A
4793348 Palmaz Dec 1988 A
4873978 Ginsburg Oct 1989 A
5011488 Ginsburg Apr 1991 A
5092839 Kipperman Mar 1992 A
5102415 Guenther et al. Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5123840 Nates Jun 1992 A
5171233 Amplatz Dec 1992 A
5234437 Sepetka Aug 1993 A
5256144 Kraus et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5372124 Takayama et al. Dec 1994 A
5385562 Adams Jan 1995 A
5387219 Rappe Feb 1995 A
5387226 Miraki Feb 1995 A
5396902 Brennen et al. Mar 1995 A
5449372 Schmaltz Sep 1995 A
5520651 Sutcu May 1996 A
5538512 Zenzon et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5558652 Henke Sep 1996 A
5601600 Ton Feb 1997 A
5609627 Goicoechea et al. Mar 1997 A
5624461 Mariant Apr 1997 A
5639277 Mariant Jun 1997 A
5645558 Horton Jul 1997 A
5658296 Bates Aug 1997 A
5662671 Barbut Sep 1997 A
5695519 Summer et al. Dec 1997 A
5709704 Nott et al. Jan 1998 A
5713853 Clark Feb 1998 A
5728078 Powers, Jr. Mar 1998 A
5769871 Mers Kelly Jun 1998 A
5779716 Cano Jul 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Danniel et al. Sep 1998 A
5827304 Hart Oct 1998 A
5855598 Pinchuk Jan 1999 A
5893869 Barnhart et al. Apr 1999 A
5895398 Wensel Apr 1999 A
5897567 Ressemann Apr 1999 A
5904698 Thomas et al. May 1999 A
5911725 Boury Jun 1999 A
5935139 Bates Aug 1999 A
5938645 Gordon Aug 1999 A
5947995 Samuels Sep 1999 A
5968057 Taheri Oct 1999 A
5971938 Hart et al. Oct 1999 A
5997939 Moechnig et al. Dec 1999 A
6022343 Johnson et al. Feb 2000 A
6063113 Kavteladze May 2000 A
6066149 Samson et al. May 2000 A
6066158 Engelson May 2000 A
6093196 Okada Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096053 Bates Aug 2000 A
6099534 Bates Aug 2000 A
6102932 Kurz Aug 2000 A
6106548 Roubin et al. Aug 2000 A
6129739 Khosravi Oct 2000 A
6146396 Kónya et al. Nov 2000 A
6146404 Kim Nov 2000 A
6165194 Denardo Dec 2000 A
6165199 Barbut Dec 2000 A
6168604 Cano Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6179861 Khosravi Jan 2001 B1
6203561 Ramee Mar 2001 B1
6214026 Lepak Apr 2001 B1
6221006 Dubrul Apr 2001 B1
6238412 Dubrul May 2001 B1
6245087 Addis Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254571 Hart Jul 2001 B1
6264663 Cano Jul 2001 B1
6306163 Fitz Oct 2001 B1
6309379 Willard Oct 2001 B1
6312444 Barbut Nov 2001 B1
6315778 Gambale et al. Nov 2001 B1
6325819 Pavcnik et al. Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6336934 Gilson et al. Jan 2002 B1
6348056 Bates Feb 2002 B1
6350271 Kurz et al. Feb 2002 B1
6361545 Macoviak Mar 2002 B1
6375668 Gifford et al. Apr 2002 B1
6383205 Samson et al. May 2002 B1
6383206 Gillick May 2002 B1
6391037 Greenhalgh May 2002 B1
6402771 Palmer Jun 2002 B1
6409683 Fonseca et al. Jun 2002 B1
6416541 Denardo Jul 2002 B2
6425909 Dieck et al. Jul 2002 B1
6432122 Gilson et al. Aug 2002 B1
6436112 Wensel Aug 2002 B2
6458139 Palmer Oct 2002 B1
6346116 Brooks et al. Nov 2002 B1
6485497 Wensel Nov 2002 B2
6485501 Green Nov 2002 B1
6485502 Don Michael Nov 2002 B2
6511492 Rosenbluth Jan 2003 B1
6517551 Driskill Feb 2003 B1
6520934 Lee et al. Feb 2003 B1
6520951 Carrillo, Jr Feb 2003 B1
6530935 Wensel Mar 2003 B2
6530939 Hopkins Mar 2003 B1
6540768 Diaz et al. Apr 2003 B1
6544279 Hopkins Apr 2003 B1
6551341 Boylan et al. Apr 2003 B2
6551342 Shen et al. Apr 2003 B1
6575997 Palmer et al. Jun 2003 B1
6582448 Boyle Jun 2003 B1
6585756 Strecker Jul 2003 B1
6589265 Palmer et al. Jul 2003 B1
6592607 Palmer et al. Jul 2003 B1
6592616 Stack Jul 2003 B1
6602271 Adams Aug 2003 B2
6602272 Boylan et al. Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6610077 Hancock et al. Aug 2003 B1
6616679 Khosravi Sep 2003 B1
6632241 Hanoock et al. Oct 2003 B1
6638245 Miller Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6641590 Palmer et al. Nov 2003 B1
6652555 VanTassel et al. Nov 2003 B1
6656218 Denardo et al. Dec 2003 B1
6660021 Palmer et al. Dec 2003 B1
6663650 Sepetka Dec 2003 B2
6673089 Yassour et al. Jan 2004 B1
6685722 Rosenbluth Feb 2004 B1
6692504 Kurz et al. Feb 2004 B2
6692508 Wensel Feb 2004 B2
6692509 Wensel Feb 2004 B2
6702782 Miller Mar 2004 B2
6712834 Yassour et al. Mar 2004 B2
6726701 Gilson et al. Apr 2004 B2
6730104 Sepetka May 2004 B1
6726703 Broome et al. Aug 2004 B2
6824545 Sepetka Nov 2004 B2
6855155 Denardo et al. Feb 2005 B2
6878163 Denardo et al. Apr 2005 B2
6890340 Duane May 2005 B2
6913612 Palmer Jul 2005 B2
6913618 Denardo et al. Jul 2005 B2
6953472 Palmer et al. Oct 2005 B2
6989019 Mazzocchi Jan 2006 B2
6989021 Bosma et al. Jan 2006 B2
6994718 Groothuis et al. Feb 2006 B2
6997939 Linder Feb 2006 B2
7004954 Voss et al. Feb 2006 B1
7004955 Shen Feb 2006 B2
7004956 Palmer Feb 2006 B2
7008434 Kurz et al. Mar 2006 B2
7033376 Tsukernik Apr 2006 B2
7041116 Goto May 2006 B2
7048758 Boyle May 2006 B2
7058456 Pierce Jun 2006 B2
7063707 Bose Jun 2006 B2
7153320 Euteneuer et al. Dec 2006 B2
7175655 Malaei Feb 2007 B1
7179273 Palmer et al. Feb 2007 B1
7220269 Ansel May 2007 B1
7220271 Clubb May 2007 B2
7226464 Garner et al. Jun 2007 B2
7229472 DePalma et al. Jun 2007 B2
7232462 Schaeffer Jun 2007 B2
7288112 Denardo et al. Oct 2007 B2
7306618 Demond Dec 2007 B2
7316692 Huffmaster Jan 2008 B2
7323001 Cubb Jan 2008 B2
7331976 McGuckin, Jr. et al. Feb 2008 B2
7344550 Carrison et al. Mar 2008 B2
7399308 Borillo et al. Jul 2008 B2
7410491 Hopkins Aug 2008 B2
7452496 Brady et al. Nov 2008 B2
7491215 Vale et al. Feb 2009 B2
7491216 Brady Feb 2009 B2
7510565 Gilson et al. Mar 2009 B2
7534252 Sepetka May 2009 B2
7556636 Mazzocchi Jul 2009 B2
7582111 Krolik et al. Sep 2009 B2
7594926 Linder Sep 2009 B2
7604649 McGuckin et al. Oct 2009 B2
7618434 Santra et al. Nov 2009 B2
7662165 Gilson et al. Feb 2010 B2
7670356 Mazzocchi Mar 2010 B2
7691121 Rosenbluth Apr 2010 B2
7691124 Balgobin Apr 2010 B2
7708770 Linder May 2010 B2
7736385 Agnew Jun 2010 B2
7766934 Pal Aug 2010 B2
7771452 Pal Aug 2010 B2
7780694 Palmer Aug 2010 B2
7780696 Daniel et al. Aug 2010 B2
7819893 Brady et al. Oct 2010 B2
7828815 Mazzocchi Nov 2010 B2
7846176 Mazzocchi Nov 2010 B2
7846175 Bonnette et al. Dec 2010 B2
7850708 Pal Dec 2010 B2
7887560 Kusleika Feb 2011 B2
7901426 Gilson et al. Mar 2011 B2
7914549 Morsi Mar 2011 B2
7922732 Mazzocchi Apr 2011 B2
7927349 Brady et al. Apr 2011 B2
7927784 Simpson Apr 2011 B2
7931659 Bose et al. Apr 2011 B2
3002822 Glocker et al. Aug 2011 A1
7998165 Huffmaster Aug 2011 B2
3021379 Thompson et al. Sep 2011 A1
3021380 Thompson et al. Sep 2011 A1
8043326 Hancock et al. Oct 2011 B2
8048151 O'Brien et al. Nov 2011 B2
8052640 Fiorella et al. Nov 2011 B2
8057497 Raju et al. Nov 2011 B1
8066757 Ferrera et al. Nov 2011 B2
8070791 Ferrera et al. Dec 2011 B2
8088140 Ferrera et al. Jan 2012 B2
8100935 Rosenbluth et al. Jan 2012 B2
8109941 Richardson Feb 2012 B2
8118829 Carrison et al. Feb 2012 B2
8123769 Osborne Feb 2012 B2
8137377 Palmer Mar 2012 B2
8142422 Makower et al. Mar 2012 B2
8142442 Palmer et al. Mar 2012 B2
8182508 Magnuson et al. May 2012 B2
8187298 Pal May 2012 B2
8246641 Osborne et al. Aug 2012 B2
8246672 Osborne Aug 2012 B2
8252017 Paul, Jr. et al. Aug 2012 B2
8252018 Valaie Aug 2012 B2
8357178 Grandfield et al. Jan 2013 B2
8357179 Grandfield et al. Jan 2013 B2
8357893 Xu et al. Jan 2013 B2
8361095 Osborne Jan 2013 B2
8366663 Fiorella Feb 2013 B2
8372133 Douk et al. Feb 2013 B2
8382742 Hermann et al. Feb 2013 B2
8409215 Sepetka et al. Apr 2013 B2
8419748 Valaie Apr 2013 B2
8460312 Bose et al. Jun 2013 B2
8460313 Huffmaster Jun 2013 B2
8486104 Samson et al. Jul 2013 B2
8529596 Grandfield et al. Sep 2013 B2
8574262 Ferrera et al. Nov 2013 B2
8579915 French et al. Nov 2013 B2
8585643 Vo et al. Nov 2013 B2
8585713 Ferrera et al. Nov 2013 B2
8608761 Osbourne et al. Dec 2013 B2
8679142 Slee et al. Mar 2014 B2
8696622 Fiorella et al. Apr 2014 B2
8702652 Fiorella et al. Apr 2014 B2
8702724 Olsen et al. Apr 2014 B2
8784434 Rosenbluth et al. Jul 2014 B2
8784441 Rosenbluth et al. Jul 2014 B2
8795305 Grandfield et al. Aug 2014 B2
8795317 Grandfield et al. Aug 2014 B2
8795345 Grandfield et al. Aug 2014 B2
8814892 Galdonik et al. Aug 2014 B2
8814925 Hilaire et al. Aug 2014 B2
8900265 Ulm, III Dec 2014 B1
8939991 Krolick et al. Jan 2015 B2
8945143 Ferrera et al. Feb 2015 B2
8945172 Ferrera et al. Feb 2015 B2
8968330 Rosenbluth et al. Mar 2015 B2
9039749 Shrivastava et al. May 2015 B2
9072537 Grandfield et al. Jul 2015 B2
9113936 Palmer et al. Aug 2015 B2
9119656 Bose et al. Sep 2015 B2
9138307 Valaie Sep 2015 B2
9149609 Ansel et al. Oct 2015 B2
9155552 Ulm, III Oct 2015 B2
9161766 Slee et al. Oct 2015 B2
9173668 Ulm, III Nov 2015 B2
9186487 Dubrul et al. Nov 2015 B2
9198687 Fulkerson et al. Dec 2015 B2
9204887 Cully et al. Dec 2015 B2
9221132 Bowman Dec 2015 B2
9232992 Heidner Jan 2016 B2
9532792 Galdonik et al. Jan 2017 B2
9532873 Kelley Jan 2017 B2
9533344 Monetti et al. Jan 2017 B2
9539011 Chen et al. Jan 2017 B2
9539022 Bowman Jan 2017 B2
9539122 Burke et al. Jan 2017 B2
9539382 Nelson Jan 2017 B2
9549830 Bruszewski et al. Jan 2017 B2
9554805 Tompkins et al. Jan 2017 B2
9561125 Bowman et al. Feb 2017 B2
9572982 Burnes et al. Feb 2017 B2
9579484 Barnell Feb 2017 B2
9585642 Dinsmoor et al. Mar 2017 B2
9615832 Bose et al. Apr 2017 B2
9615951 Bennett et al. Apr 2017 B2
9622753 Cox Apr 2017 B2
9636115 Henry et al. May 2017 B2
9636439 Chu et al. May 2017 B2
9642635 Vale et al. May 2017 B2
9642675 Werneth et al. May 2017 B2
9655633 Leynov et al. May 2017 B2
9655645 Staunton May 2017 B2
9655989 Cruise et al. May 2017 B2
9662129 Galdonik et al. May 2017 B2
9662238 Dwork et al. May 2017 B2
9662425 Lilja et al. May 2017 B2
9668898 Wong Jun 2017 B2
9675477 Thompson Jun 2017 B2
9675782 Connolly Jun 2017 B2
9676022 Ensign et al. Jun 2017 B2
9692557 Murphy Jun 2017 B2
9693852 Lam et al. Jul 2017 B2
9700262 Janik et al. Jul 2017 B2
9700399 Acosta-Acevedo Jul 2017 B2
9717421 Griswold et al. Aug 2017 B2
9717500 Tieu et al. Aug 2017 B2
9717502 Teoh et al. Aug 2017 B2
9724103 Cruise et al. Aug 2017 B2
9724526 Strother et al. Aug 2017 B2
9750565 Bloom et al. Sep 2017 B2
9757260 Greenan Sep 2017 B2
9764111 Gulachenski Sep 2017 B2
9770251 Bowman et al. Sep 2017 B2
9770577 Li et al. Sep 2017 B2
9775621 Tompkins et al. Oct 2017 B2
9775706 Peterson et al. Oct 2017 B2
9775732 Khenansho Oct 2017 B2
9788800 Mayoras, Jr. Oct 2017 B2
9795391 Saatchi et al. Oct 2017 B2
9801980 Karino et al. Oct 2017 B2
9808599 Bowman et al. Nov 2017 B2
9833252 Sepetka et al. Dec 2017 B2
9833604 Lam et al. Dec 2017 B2
9833625 Waldhauser et al. Dec 2017 B2
10028759 Wallace et al. Jul 2018 B2
10149692 Turjman et al. Dec 2018 B2
10265086 Vale Apr 2019 B2
10716915 Ogle et al. Jul 2020 B2
10610668 Burkholz et al. Aug 2020 B2
20010001315 Bates May 2001 A1
20010011182 Dubrul Aug 2001 A1
20010016755 Addis Aug 2001 A1
20010041899 Foster Nov 2001 A1
20010044598 Parodi Nov 2001 A1
20010044634 Don Michael et al. Nov 2001 A1
20010051810 Dubrul Dec 2001 A1
20020002383 Sepetka et al. Jan 2002 A1
20020016609 Wensel Feb 2002 A1
20020022859 Hogendijk Feb 2002 A1
20020026211 Khosravi Feb 2002 A1
20020049468 Streeter Apr 2002 A1
20020052620 Barvut May 2002 A1
20020068954 Foster Jun 2002 A1
20020072764 Sepetka Jun 2002 A1
20020082558 Samson Jun 2002 A1
20020091407 Zadno-Azizi et al. Jul 2002 A1
20020095171 Belef Jul 2002 A1
20020123765 Sepetka Sep 2002 A1
20020143362 Macoviak et al. Oct 2002 A1
20020156455 Barbut Oct 2002 A1
20020161393 Demond Oct 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020173819 Leeflang et al. Nov 2002 A1
20020177800 Bagaoisan et al. Nov 2002 A1
20020188276 Evans Dec 2002 A1
20030004536 Boylan et al. Jan 2003 A1
20030004538 Secrest Jan 2003 A1
20030004542 Wensel Jan 2003 A1
20030009146 Muni Jan 2003 A1
20030009191 Wensel Jan 2003 A1
20030023204 Vo et al. Jan 2003 A1
20030040769 Kelley et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030050663 Khachin Mar 2003 A1
20030105484 Boyle et al. Jun 2003 A1
20030125798 Matrin Jul 2003 A1
20030130682 Broome et al. Jul 2003 A1
20030144687 Brady et al. Jul 2003 A1
20030153940 Nohilly et al. Aug 2003 A1
20030153943 Michael et al. Aug 2003 A1
20030153944 Phung Aug 2003 A1
20030163064 Vrba Aug 2003 A1
20030163158 Wlite Aug 2003 A1
20030171769 Barbul Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030195537 Dubrul Oct 2003 A1
20030195554 Shen Oct 2003 A1
20030199917 Knudson Oct 2003 A1
20030204202 Palmer Oct 2003 A1
20030212430 Bose Nov 2003 A1
20030216611 Vu Nov 2003 A1
20030236533 Wilson Dec 2003 A1
20040010280 Adams et al. Jan 2004 A1
20040010282 Kusleika Jan 2004 A1
20040014002 Lundgren Jan 2004 A1
20040068288 Palmer et al. Apr 2004 A1
20040073243 Sepetka Apr 2004 A1
20040079429 Miller Apr 2004 A1
20040082962 Demarais et al. Apr 2004 A1
20040093065 Yachia et al. May 2004 A1
20040133231 Maitland Jul 2004 A1
20040138692 Phung Jul 2004 A1
20040153118 Clubb Aug 2004 A1
20040193107 Pierpont et al. Sep 2004 A1
20040199202 Dubrul et al. Oct 2004 A1
20040260333 Dubrul et al. Dec 2004 A1
20050015047 Shah Jan 2005 A1
20050020974 Noriega Jan 2005 A1
20050033348 Sepetka Feb 2005 A1
20050038447 Huffmaster Feb 2005 A1
20050038468 Panetta et al. Feb 2005 A1
20050049619 Sepetka Mar 2005 A1
20050049669 Jones Mar 2005 A1
20050049670 Jones et al. Mar 2005 A1
20050055033 Leslie et al. Mar 2005 A1
20050055047 Greenhalgh Mar 2005 A1
20050059995 Sepetka Mar 2005 A1
20050085849 Sepetka Apr 2005 A1
20050090857 Kusleika et al. Apr 2005 A1
20050125024 Sepetka Jun 2005 A1
20050149111 Kanazawa et al. Jul 2005 A1
20050171566 Kanamaru Aug 2005 A1
20050187570 Nguyen et al. Aug 2005 A1
20050267491 Kellett et al. Aug 2005 A1
20050216030 Sepetka Sep 2005 A1
20050216050 Sepetka Sep 2005 A1
20050288686 Sepetka Sep 2005 A1
20050228417 Teitelbaum et al. Oct 2005 A1
20060009785 Maitland et al. Jan 2006 A1
20060009799 Kleshinski et al. Jan 2006 A1
20060010636 Vacher Jan 2006 A1
20060030933 DeLeggge et al. Feb 2006 A1
20060058836 Bose Mar 2006 A1
20060058837 Bose Mar 2006 A1
20060058838 Bose Mar 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060149313 Arguello et al. Jul 2006 A1
20060155305 Freudenthal Jul 2006 A1
20060155322 Safer et al. Jul 2006 A1
20060161187 Levine et al. Jul 2006 A1
20060195137 Sepetka Aug 2006 A1
20060224177 Finitsis Oct 2006 A1
20060224179 Kucharczyk Oct 2006 A1
20060229638 Abrams et al. Oct 2006 A1
20060282111 Morsi Dec 2006 A1
20060287701 Pal Dec 2006 A1
20070088383 Pal et al. Apr 2007 A1
20070142858 Bates Jun 2007 A1
20070149996 Coughlin Jun 2007 A1
20070156170 Hancock Jul 2007 A1
20070165170 Fukuda Jul 2007 A1
20070191866 Palmer et al. Aug 2007 A1
20070198028 Miloslavski Aug 2007 A1
20070198051 Clubb et al. Aug 2007 A1
20070198075 Levy Aug 2007 A1
20070208367 Fiorella Sep 2007 A1
20070208371 French Sep 2007 A1
20070213765 Adams et al. Sep 2007 A1
20070225749 Martin Sep 2007 A1
20070239254 Chia et al. Oct 2007 A1
20070244505 Gilson et al. Oct 2007 A1
20070270902 Slazas et al. Nov 2007 A1
20070288038 Bimbo Dec 2007 A1
20070293887 Okushi Dec 2007 A1
20080045881 Teitelbaum et al. Feb 2008 A1
20080082107 Miller et al. Apr 2008 A1
20080086190 Ta Apr 2008 A1
20080091223 Pokorney Apr 2008 A1
20080097398 Mitelberg Apr 2008 A1
20080109031 Sepetka May 2008 A1
20080109032 Sepetka May 2008 A1
20080119886 Greenhalgh et al. May 2008 A1
20080177296 Sepetka Jul 2008 A1
20080183197 Sepetka Jul 2008 A1
20080183198 Sepetka Jul 2008 A1
20080183205 Sepetka Jul 2008 A1
20080188876 Sepetka Aug 2008 A1
20080188885 Sepetka Aug 2008 A1
20080188928 Salahieh Aug 2008 A1
20080200946 Braun Aug 2008 A1
20080215077 Sepetka Sep 2008 A1
20080221600 Dieck et al. Sep 2008 A1
20080228209 DeMello et al. Sep 2008 A1
20080234706 Sepetka Sep 2008 A1
20080243170 Jenson Oct 2008 A1
20080255596 Jenson Oct 2008 A1
20080262528 Martin Oct 2008 A1
20080262532 Martin Oct 2008 A1
20080275488 Fleming Nov 2008 A1
20080275493 Farmiga Nov 2008 A1
20080281350 Sepetka Nov 2008 A1
20080312681 Ansel Dec 2008 A1
20090024157 Anukhin Jan 2009 A1
20090054918 Henson Feb 2009 A1
20090069828 Martin Mar 2009 A1
20090076539 Valaie Mar 2009 A1
20090105722 Fulkerson Apr 2009 A1
20090105737 Fulkerson Apr 2009 A1
20090131908 McKay May 2009 A1
20090163846 Aklog et al. May 2009 A1
20090177206 Lozier et al. Jul 2009 A1
20090182336 Brenzel et al. Jul 2009 A1
20090221967 Thommen et al. Sep 2009 A1
20090270815 Stamp et al. Oct 2009 A1
20090281610 Parker Nov 2009 A1
20090292297 Ferrere Nov 2009 A1
20090292307 Razack Nov 2009 A1
20090299374 Tilson et al. Dec 2009 A1
20090299393 Martin Dec 2009 A1
20090306702 Miloslavski Dec 2009 A1
20100004607 Wilson et al. Jan 2010 A1
20100030186 Stivland Feb 2010 A1
20100030256 Dubrul et al. Feb 2010 A1
20100087908 Hilaire Apr 2010 A1
20100114017 Lenker May 2010 A1
20100125326 Kalstad May 2010 A1
20100125327 Agnew May 2010 A1
20100191272 Keating Jul 2010 A1
20100211094 Sargent, Jr. Aug 2010 A1
20100249815 Jantzen et al. Sep 2010 A1
20100268264 Bonnett et al. Oct 2010 A1
20100268265 Krolik et al. Oct 2010 A1
20100292726 Olsen et al. Nov 2010 A1
20100305604 Pah Dec 2010 A1
20100318178 Rapaport et al. Dec 2010 A1
20100324649 Mattsson Dec 2010 A1
20100331949 Habib Dec 2010 A1
20110009875 Grandfield et al. Jan 2011 A1
20110009940 Grandfield et al. Jan 2011 A1
20110009942 Gregorich Jan 2011 A1
20110022149 Cox et al. Jan 2011 A1
20110054514 Arcand Mar 2011 A1
20110054516 Keegan Mar 2011 A1
20110060359 Hannes Mar 2011 A1
20110077620 deBeer Mar 2011 A1
20110098683 Wiita et al. Apr 2011 A1
20110054504 Wolf et al. May 2011 A1
20110125181 Brady et al. May 2011 A1
20110130756 Everson, Jr. et al. Jun 2011 A1
20110152920 Eckhouse et al. Jun 2011 A1
20110160763 Ferrera et al. Jun 2011 A1
20110166586 Sepetka et al. Jul 2011 A1
20110196414 Porter et al. Aug 2011 A1
20110202088 Eckhouse et al. Aug 2011 A1
20110213290 Chin et al. Sep 2011 A1
20110213297 Aklog et al. Sep 2011 A1
20110213393 Aklog et al. Sep 2011 A1
20110213403 Aboytes Sep 2011 A1
20110218564 Drasler et al. Sep 2011 A1
20110224707 Miloslavaski et al. Sep 2011 A1
20110264132 Strauss et al. Oct 2011 A1
20110276120 Gilson et al. Nov 2011 A1
20110319917 Ferrera et al. Dec 2011 A1
20120041449 Eckhouse et al. Feb 2012 A1
20120041474 Eckhouse et al. Feb 2012 A1
20120059356 diPama et al. Mar 2012 A1
20120089216 Rapaport et al. Apr 2012 A1
20120101510 Lenker et al. Apr 2012 A1
20120116351 Chomas et al. May 2012 A1
20120116440 Leynov et al. May 2012 A1
20120143237 Cam et al. Jun 2012 A1
20120143239 Aklog et al. Jun 2012 A1
20120150147 Leynov et al. Jun 2012 A1
20120165858 Eckhouse et al. Jun 2012 A1
20120165859 Eckhouse et al. Jun 2012 A1
20120215250 Grandfield et al. Aug 2012 A1
20120277788 Cattaneo Nov 2012 A1
20120283768 Cox et al. Nov 2012 A1
20120296362 Cam et al. Nov 2012 A1
20120316600 Ferrera et al. Dec 2012 A1
20130006284 Aggerholm et al. Jan 2013 A1
20130030461 Marks et al. Jan 2013 A1
20130046330 McIntosh et al. Feb 2013 A1
20130046333 Jones et al. Feb 2013 A1
20130046334 Jones et al. Feb 2013 A1
20130116774 Strauss et al. May 2013 A1
20130131614 Hassan et al. May 2013 A1
20130144326 Brady et al. Jun 2013 A1
20130144328 Weber et al. Jun 2013 A1
20130158592 Porter Jun 2013 A1
20130184703 Shireman et al. Jul 2013 A1
20130184739 Brady et al. Jul 2013 A1
20130197567 Brady et al. Aug 2013 A1
20130226146 Tekulve Aug 2013 A1
20130268050 Wilson et al. Oct 2013 A1
20130281788 Garrison Oct 2013 A1
20130289697 Baker Oct 2013 A1
20130325055 Eckhouse et al. Dec 2013 A1
20130325056 Eckhouse et al. Dec 2013 A1
20130345739 Brady et al. Dec 2013 A1
20140046359 Bowman et al. Feb 2014 A1
20140121672 Folk May 2014 A1
20140128905 Molaei May 2014 A1
20140135812 Divino et al. May 2014 A1
20140180377 Bose et al. Jun 2014 A1
20140188127 Dubrul et al. Jul 2014 A1
20140194919 Losardo et al. Jul 2014 A1
20140200607 Sepetka et al. Jul 2014 A1
20140200608 Brady et al. Jul 2014 A1
20140236220 Inoue Aug 2014 A1
20140257362 Eldenschink Sep 2014 A1
20140276922 McLain et al. Sep 2014 A1
20140277053 Wang et al. Sep 2014 A1
20140277079 Vale et al. Sep 2014 A1
20140309657 Ben-Ami Oct 2014 A1
20140309673 Dacuycuy et al. Oct 2014 A1
20140330302 Tekulve et al. Nov 2014 A1
20140343585 Ferrera et al. Nov 2014 A1
20140364896 Consigny Dec 2014 A1
20140371769 Vale et al. Dec 2014 A1
20140371779 Vale et al. Dec 2014 A1
20140371780 Vale et al. Dec 2014 A1
20140379023 Brady et al. Dec 2014 A1
20150018859 Quick et al. Jan 2015 A1
20150018860 Quick et al. Jan 2015 A1
20150080937 Davidson Mar 2015 A1
20150081003 Wainwright et al. Mar 2015 A1
20150112376 Molaei et al. Apr 2015 A1
20150133990 Davidson May 2015 A1
20150142043 Furey May 2015 A1
20150164523 Brady et al. Jun 2015 A1
20150238314 Börtlein et al. Aug 2015 A1
20150250497 Marks et al. Sep 2015 A1
20150257775 Gilvarry et al. Sep 2015 A1
20150297252 Miloslavski et al. Oct 2015 A1
20150306311 Pinchuk Oct 2015 A1
20150313617 Grandfield et al. Nov 2015 A1
20150320431 Ulm, III Nov 2015 A1
20150351770 Fulton, III Dec 2015 A1
20150352325 Quick Dec 2015 A1
20150359547 Vale et al. Dec 2015 A1
20150374391 Quick et al. Dec 2015 A1
20150374393 Brady et al. Dec 2015 A1
20150374479 Vale Dec 2015 A1
20160015402 Brady et al. Jan 2016 A1
20160022296 Brady et al. Jan 2016 A1
20160066921 Brady et al. Mar 2016 A1
20160074067 Furnish et al. Mar 2016 A1
20160106448 Brady et al. Apr 2016 A1
20160106449 Brady et al. Apr 2016 A1
20160113663 Brady et al. Apr 2016 A1
20160113664 Brady et al. Apr 2016 A1
20160113665 Brady et al. Apr 2016 A1
20160120558 Brady et al. May 2016 A1
20160121080 Cottone May 2016 A1
20160135829 Holochwost et al. May 2016 A1
20160143653 Vale et al. May 2016 A1
20160151079 Aklog et al. Jun 2016 A1
20160192953 Brady et al. Jul 2016 A1
20160192954 Brady et al. Jul 2016 A1
20160192955 Brady et al. Jul 2016 A1
20160192956 Brady et al. Jul 2016 A1
20160228134 Martin et al. Aug 2016 A1
20160256180 Vale et al. Sep 2016 A1
20160262880 Li et al. Sep 2016 A1
20160317168 Brady et al. Nov 2016 A1
20170007264 Cruise et al. Jan 2017 A1
20170007265 Guo et al. Jan 2017 A1
20170020670 Murray et al. Jan 2017 A1
20170020700 Bienvenu et al. Jan 2017 A1
20170027640 Kunis et al. Feb 2017 A1
20170027692 Bonhoeffer et al. Feb 2017 A1
20170027725 Argentine Feb 2017 A1
20170035436 Morita Feb 2017 A1
20170035567 Duffy Feb 2017 A1
20170042548 Lam Feb 2017 A1
20170049596 Schabert Feb 2017 A1
20170065401 Fearnot et al. Mar 2017 A1
20170071614 Vale et al. Mar 2017 A1
20170071737 Kelley Mar 2017 A1
20170072452 Monetti et al. Mar 2017 A1
20170079671 Morero et al. Mar 2017 A1
20170079680 Bowman Mar 2017 A1
20170079766 Wang et al. Mar 2017 A1
20170079767 Leon-Yip Mar 2017 A1
20170079812 Lam et al. Mar 2017 A1
20170079817 Sepetka et al. Mar 2017 A1
20170079819 Pung et al. Mar 2017 A1
20170079820 Lam et al. Mar 2017 A1
20170086851 Wallace et al. Mar 2017 A1
20170086862 Vale et al. Mar 2017 A1
20170086863 Brady et al. Mar 2017 A1
20170086996 Peterson et al. Mar 2017 A1
20170095259 Tompkins et al. Apr 2017 A1
20170100126 Bowman et al. Apr 2017 A1
20170100141 Morero et al. Apr 2017 A1
20170100143 Granfield Apr 2017 A1
20170100183 Iaizzo et al. Apr 2017 A1
20170105743 Vale et al. Apr 2017 A1
20170112515 Brady et al. Apr 2017 A1
20170113023 Steingisser et al. Apr 2017 A1
20170147765 Mehta May 2017 A1
20170151032 Loisel Jun 2017 A1
20170165062 Rothstein Jun 2017 A1
20170165065 Rothstein et al. Jun 2017 A1
20170165454 Tuohy et al. Jun 2017 A1
20170172554 Bortlein et al. Jun 2017 A1
20170172581 Bose et al. Jun 2017 A1
20170172766 Vong et al. Jun 2017 A1
20170172772 Khenansho Jun 2017 A1
20170189033 Sepetka et al. Jul 2017 A1
20170189035 Porter Jul 2017 A1
20170215902 Leynov et al. Aug 2017 A1
20170216484 Cruise et al. Aug 2017 A1
20170224350 Shimizu et al. Aug 2017 A1
20170224355 Bowman et al. Aug 2017 A1
20170224467 Piccagli et al. Aug 2017 A1
20170224511 Dwork et al. Aug 2017 A1
20170224953 Tran et al. Aug 2017 A1
20170231749 Perkins et al. Aug 2017 A1
20170252064 Staunton Sep 2017 A1
20170265983 Lam et al. Sep 2017 A1
20170281192 Tieu et al. Oct 2017 A1
20170281331 Perkins et al. Oct 2017 A1
20170281344 Costello Oct 2017 A1
20170281909 Northrop et al. Oct 2017 A1
20170281912 Melder et al. Oct 2017 A1
20170290593 Sethna Oct 2017 A1
20170290654 Sethna Oct 2017 A1
20170296324 Argentine Oct 2017 A1
20170296325 Marrocco et al. Oct 2017 A1
20170303939 Greenhalgh et al. Oct 2017 A1
20170303942 Greenhalgh et al. Oct 2017 A1
20170303947 Greenhalgh et al. Oct 2017 A1
20170303948 Wallace et al. Oct 2017 A1
20170304041 Argentine Oct 2017 A1
20170304097 Corwin et al. Oct 2017 A1
20170304595 Nagasrinivasa et al. Oct 2017 A1
20170312109 Le Nov 2017 A1
20170312484 Shipley et al. Nov 2017 A1
20170316561 Helm et al. Nov 2017 A1
20170319826 Bowman et al. Nov 2017 A1
20170333228 Orth et al. Nov 2017 A1
20170333236 Greenan Nov 2017 A1
20170333678 Bowman et al. Nov 2017 A1
20170340383 Bloom et al. Nov 2017 A1
20170348014 Wallace et al. Dec 2017 A1
20170348514 Guyon et al. Dec 2017 A1
20180008407 Maimon et al. Jan 2018 A1
20180042623 Batiste Feb 2018 A1
20180193591 Jaroch et al. Jul 2018 A1
20180235743 Farago et al. Aug 2018 A1
20190021755 Johnson et al. Jan 2019 A1
20190021759 Krolik et al. Jan 2019 A1
20190029820 Zhou et al. Jan 2019 A1
20190029825 Fitterer et al. Jan 2019 A1
20190046219 Marchand et al. Feb 2019 A1
20190192175 Chida et al. Jun 2019 A1
20190209206 Patel et al. Jul 2019 A1
20190216476 Barry et al. Jul 2019 A1
20190239907 Brady et al. Aug 2019 A1
20190255290 Snyder et al. Aug 2019 A1
20190365411 Avneri et al. Dec 2019 A1
20220125450 Sirhan et al. Apr 2022 A1
Foreign Referenced Citations (99)
Number Date Country
1658920 Aug 2005 CN
103071195 May 2013 CN
104507380 Apr 2015 CN
104905873 Sep 2015 CN
105007973 Oct 2015 CN
105307582 Feb 2016 CN
105726163 Jul 2016 CN
106232059 Dec 2016 CN
113040865 Jun 2021 CN
20 2009 001 951 Apr 2010 DE
10 2009 056 450 Jun 2011 DE
10 2010 010 849 Sep 2011 DE
10 2010 014 778 Oct 2011 DE
10 2010 024 085 Dec 2011 DE
10 2011 014 586 Sep 2012 DE
20 2020 107013 Jan 2021 DE
2301450 Mar 2011 EP
2628455 Aug 2013 EP
3302312 Apr 2018 EP
3335647 Jun 2018 EP
3 420 978 Jan 2019 EP
2498349 Jul 2013 GB
1972728 May 2007 GN
9-19438 Jan 1997 JP
WO 9304722 Mar 1993 WO
9424926 Nov 1994 WO
9727808 Aug 1997 WO
9738631 Oct 1997 WO
9920335 Apr 1999 WO
9956801 Nov 1999 WO
9960933 Dec 1999 WO
0121077 Mar 2001 WO
0202162 Jan 2002 WO
0211627 Feb 2002 WO
0243616 Jun 2002 WO
02070061 Sep 2002 WO
02094111 Nov 2002 WO
03002006 Jan 2003 WO
03018085 Mar 2003 WO
03030751 Apr 2003 WO
03051448 Jun 2003 WO
2004028571 Apr 2004 WO
2004056275 Jul 2004 WO
2005000130 Jan 2005 WO
2005027779 Mar 2005 WO
WO 2005027751 Mar 2005 WO
2006021407 Mar 2006 WO
2006031410 Mar 2006 WO
2006107641 Oct 2006 WO
2006135823 Dec 2006 WO
2007054307 May 2007 WO
2007068424 Jun 2007 WO
2008034615 Mar 2008 WO
2008051431 May 2008 WO
2008131116 Oct 2008 WO
WO 2009019664 Feb 2009 WO
2009031338 Mar 2009 WO
2009076482 Jun 2009 WO
2009086482 Jul 2009 WO
2009105710 Aug 2009 WO
WO 2009103125 Aug 2009 WO
2010010545 Jan 2010 WO
2010046897 Apr 2010 WO
2010075565 Jul 2010 WO
2010102307 Sep 2010 WO
2010146581 Dec 2010 WO
2011013556 Feb 2011 WO
2011066961 Jun 2011 WO
2011082319 Jul 2011 WO
2011095352 Aug 2011 WO
2011106426 Sep 2011 WO
2011110316 Sep 2011 WO
2012052982 Apr 2012 WO
2012064726 May 2012 WO
2012081020 Jun 2012 WO
2012110619 Aug 2012 WO
2012120490 Sep 2012 WO
2012156924 Nov 2012 WO
2013016435 Jan 2013 WO
2013072777 May 2013 WO
2013105099 Jul 2013 WO
2013109756 Jul 2013 WO
2014081892 May 2014 WO
2014139845 Sep 2014 WO
2014169266 Oct 2014 WO
2014178198 Nov 2014 WO
2015061365 Apr 2015 WO
2015134625 Sep 2015 WO
2015179324 Nov 2015 WO
WO 2015179377 Nov 2015 WO
2015189354 Dec 2015 WO
2016010995 Jan 2016 WO
WO 2017004234 Jan 2017 WO
WO 2017097616 Jun 2017 WO
2018193603 Oct 2018 WO
WO 2018178979 Oct 2018 WO
WO 2019064306 Apr 2019 WO
WO 2019079296 Apr 2019 WO
WO 2020139979 Jul 2020 WO
Non-Patent Literature Citations (3)
Entry
US 6,348,062 B1, 02/2002, Hopkins (withdrawn)
Extended European Search Report issued in corresponding European Patent Application No. 20 19 5533 dated Feb. 8, 2021.
Struffert, T., et al. “Intravenous flat detector CT angiography for non-invasive visualisation of intracranial flow diverter: technical feasibility” Eur Radiol 21:1797-1801 (2011).
Related Publications (1)
Number Date Country
20210069468 A1 Mar 2021 US
Provisional Applications (1)
Number Date Country
62898864 Sep 2019 US